PS7	O
Familial	BP
hemophagocytosis-2	IP
is	O
a	O
rare	O
disease	O
associated	O
with	O
defects	BG
in	IG
proteins	IG
involved	IG
in	IG
CD8-14	IG
+	IG
T	IG
-	IG
cell	IG
cytotoxicity	IG
.	O

PS62	O
Germline	O
mutations	O
in	O
the	O
human	BG
transcription	IG
factor	IG
genes-8	IG
have	O
been	O
associated	O
with	O
congenital	BP
heart	IP
disease-15	IP
,	O
but	O
familial	O
cases	O
studied	O
so	O
far	O
have	O
different	O
mutations	O
.	O

PS85	O
The	O
human	BG
Cytochrome	IG
P450	IG
gene	IG
CYP1B1-6	IG
has	O
been	O
implicated	O
in	O
primary	O
congenital	BP
glaucoma	IP
worldwide-14	IP
.	O

PS112	O
The	O
FcgammaRIIIa	BG
F	IG
/	IG
F	IG
genotype-6	IG
was	O
also	O
associated	O
with	O
nephritis-11	BP
(	O
WHO	O
class	O
III	O
and	O
IV	O
,	O
P	O
=	O
0	O
.	O
04	O
for	O
the	O
systemic	BP
lupus	IP
erythematosus-28	IP
group	O
)	O
and	O
in	O
combination	O
with	O
the	O
CRP4	BG
A-37	IG
-	IG
allele	IG
a	O
stronger	O
association	O
was	O
noted	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

PS113	O
An	O
association	O
was	O
found	O
between	O
seizures-6	BP
and	O
the	O
presence	O
of	O
both	O
the	O
FcgammaRIIa	BG
R-14	IG
/	IG
R-16	IG
and	O
the	O
FcgammaRIIIa	BG
F	IG
/	IG
F-22	IG
genotypes	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
an	O
inverse	O
correlation	O
between	O
serositis	BP
and	O
the	O
CRP4	BG
A	IG
-	IG
allele-42	IG
when	O
present	O
together	O
with	O
the	O
IL	BG
-	IG
1Ra	IG
2	IG
-	IG
allele-53	IG
(	O
P	O
=	O
0	O
.	O
01	O
)	O
.	O

PS114	O
Furthermore	O
,	O
a	O
combination	O
of	O
the	O
FcgammaRIIa	BG
R	IG
/	IG
R	IG
genotype-11	IG
and	O
CRP4	BG
A	IG
-	IG
allele-16	IG
was	O
associated	O
with	O
lymphopenia-20	BP
(	O
P	O
=	O
0	O
.	O
02	O
)	O
and	O
a	O
similar	O
result	O
was	O
found	O
for	O
the	O
combination	O
of	O
FcgammaRIIIa	BG
F	IG
/	IG
F-41	IG
and	O
FcgammaRIIIb	BG
NA2-44	IG
/	IG
NA2-46	IG
(	O
P	O
=	O
0	O
.	O
04	O
)	O
.	O

PS115	O
Polymorphic	O
variants	O
of	O
the	O
CRP-5	BG
and	O
Fcgamma	BG
-	IG
receptor	IG
genes-10	IG
are	O
associated	O
with	O
the	O
clinical	O
phenotype	O
in	O
systemic	BP
lupus	IP
erythematosus-20	IP
.	O

PS138	O
Also	O
,	O
the	O
progression	O
to	O
generalized	BP
dystonia-7	IP
in	O
DYT1-9	BG
-	O
positive	O
patients	O
was	O
significantly	O
higher	O
than	O
in	O
DYT1-18	BG
-	O
negative	O
patients	O
.	O

PS144	O
Meanwhile	O
,	O
IGF	BG
-	IG
binding	IG
protein	IG
3	IG
-	IG
202CC	IG
genotype-10	IG
was	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
prostate	BP
cancer-19	IP
with	O
borderline	O
significance	O
(	O
OR	O
,	O
1	O
.	O
18	O
,	O
95	O
%	O
CI	O
,	O
0	O
.	O
99	O
-	O
1	O
.	O
41	O
)	O
.	O

PS148	O
Linkage	O
analysis	O
with	O
data	O
from	O
a	O
dizygotic	O
twin	O
set	O
showed	O
a	O
suggestive	O
linkage	O
at	O
the	O
Bcholinesterase	BG
locus-17	IG
,	O
and	O
statistical	O
analysis	O
revealed	O
a	O
high	O
correlation	O
between	O
Bcholinesterase-27	BG
activity	O
and	O
variables	O
associated	O
with	O
cardiovascular	BP
risk-34	IP
and	O
the	O
metabolic	O
syndrome	O
.	O

PS149	O
Although	O
several	O
studies	O
had	O
explored	O
the	O
association	O
between	O
the	O
CYP2D6	BG
*	IG
10	IG
C188T-13	IG
polymorphism	O
,	O
which	O
encodes	O
the	O
phenotype	O
intermediate	O
metabolizers	O
,	O
and	O
tardive	BP
dyskinesia-25	IP
in	O
Orientals	O
,	O
the	O
findings	O
were	O
inconclusive	O
.	O

PS151	O
We	O
concluded	O
that	O
the	O
CYP2D6	BG
*	IG
10	IG
C188T-8	IG
polymorphism	O
may	O
be	O
associated	O
with	O
the	O
susceptibility	O
to	O
the	O
occurrence	O
of	O
tardive	BP
dyskinesia-21	IP
induced	O
by	O
typical	O
antipsychotics	O
,	O
especially	O
in	O
male	O
patients	O
,	O
and	O
may	O
also	O
be	O
correlated	O
with	O
Abnormal	O
Involuntary	O
Movement	O
Scale	O
scores	O
in	O
tardive	BP
dyskinesia-45	IP
patients	O
.	O

PS160	O
Hereditary	O
angioedema-2	BP
was	O
diagnosed	O
based	O
on	O
clinical	O
features	O
and	O
C1-10	BG
inhibitor	IG
deficiency	IG
.	O

PS175	O
Reduced	O
heart	O
rate	O
variability	O
and	O
increased	O
C	BG
-	IG
reactive	IG
protein-10	IG
levels	O
are	O
both	O
predictors	O
of	O
coronary	BP
artery	IP
disease-18	IP
and	O
correlate	O
with	O
each	O
other	O
.	O

PS192	O
The	O
SAA1	BG
-	IG
alpha	IG
/	IG
alpha	IG
genotype-7	IG
was	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
amyloidosis-15	BP
.	O

PS204	O
Our	O
data	O
on	O
a	O
small	O
number	O
of	O
women	O
with	O
symptoms	O
of	O
muscle	O
disease	O
indicate	O
that	O
abnormal	O
patterns	O
of	O
dystrophin	O
labelling	O
on	O
sections	O
may	O
be	O
an	O
effective	O
way	O
of	O
differentiating	O
between	O
female	O
patients	O
with	O
a	O
form	O
of	O
limb	O
girdle	BP
dystrophy-39	IP
and	O
those	O
carrying	O
a	O
defective	O
Xp21	BG
gene-46	IG
.	O

PS209	O
Steroid	BG
11beta	IG
-	IG
hydroxylase-4	IG
deficiency	O
(	O
11OHD	O
)	O
,	O
the	O
second	O
cause	O
of	O
congenital	BP
adrenal	IP
hyperplasia-16	IP
,	O
accounts	O
only	O
for	O
5	O
%	O
of	O
all	O
congenital	BP
adrenal	IP
hyperplasia-27	IP
.	O

PS215	O
The	O
results	O
demonstrate	O
that	O
C	BG
-	IG
reactive	IG
protein-8	IG
production	O
may	O
be	O
related	O
to	O
the	O
presence	O
of	O
abdominal	BP
aortic	IP
aneurysm-19	IP
,	O
especially	O
in	O
advanced	O
disease	O
.	O

PS220	O
We	O
found	O
that	O
rs11614913	BG
CC-5	IG
was	O
associated	O
with	O
a	O
significantly	O
increased	O
risk	O
of	O
congenital	BP
heart	IP
disease-16	IP
in	O
all	O
three	O
stages	O
combined	O
(	O
P	O
=	O
6	O
.	O
81	O
x	O
10	O
(	O
-	O
6	O
)	O
)	O
.	O

PS233	O
Mutations	O
in	O
ABCC8-3	BG
and	O
KCNJ11-5	BG
are	O
the	O
most	O
common	O
causes	O
of	O
Congenital	BP
hyperinsulinism-13	IP
in	O
Korean	O
patients	O
.	O

PS235	O
The	O
paraoxonase	O
(	O
PON1-4	BG
)	O
polymorphisms	O
,	O
Leu55Met	O
and	O
Gln192Arg	O
,	O
modulate	O
intima	O
-	O
medial	O
artery	O
thickening	O
,	O
prognosis	O
of	O
cardiovascular	O
stroke-22	BP
,	O
and	O
renal	BP
failure-26	IP
in	O
other	O
diseases	O
.	O

PS236	O
Increased	O
expression	O
of	O
cyclin	BG
D1-5	IG
,	O
p53-7	BG
,	O
Ki	BG
-	IG
67-11	IG
,	O
beta	BG
-	IG
catenine-15	IG
and	O
Her	BG
-	IG
2-19	IG
/	O
neu-21	BG
,	O
and	O
decreased	O
expression	O
of	O
p27-27	BG
may	O
be	O
important	O
events	O
in	O
the	O
three	O
ethnic	O
groups	O
with	O
colorectal	BP
cancer-39	IP
.	O

PS241	O
The	O
authors	O
report	O
their	O
experience	O
regarding	O
the	O
identification	O
of	O
Apo	BG
-	IG
E	IG
alleles-13	IG
on	O
atheroma-15	BP
carotid	O
plaques	O
in	O
20	O
patients	O
of	O
both	O
sexes	O
diagnosed	O
as	O
suffering	O
from	O
severe	O
carotid	O
stenosis	O
using	O
Doppler	O
tests	O
.	O

PS243	O
It	O
is	O
difficult	O
to	O
draw	O
any	O
conclusions	O
from	O
the	O
alleles	O
found	O
in	O
the	O
other	O
5	O
patients	O
due	O
to	O
their	O
scarce	O
statistical	O
value	O
and	O
the	O
limited	O
number	O
of	O
carotid	O
plaques	O
examined	O
,	O
but	O
there	O
appears	O
to	O
be	O
some	O
sort	O
of	O
correlation	O
between	O
calcified	O
plaque	O
,	O
hyperlipidemia-45	BP
and	O
the	O
allele	O
Apo	BG
E	IG
-	IG
2	IG
/	IG
E	IG
-	IG
2-56	IG
,	O
with	O
an	O
interchange	O
of	O
position	O
between	O
cysteine	O
arginine	O
amino	O
acids	O
in	O
the	O
Apo	BG
E	IG
sequences-72	IG
.	O

PS258	O
Our	O
findings	O
are	O
useful	O
in	O
understanding	O
the	O
prevalence	O
of	O
GATA4-10	BG
mutations	O
and	O
the	O
correlation	O
between	O
the	O
GATA4	BG
genotype-18	IG
and	O
the	O
congenital	BP
heart	IP
disease-23	IP
phenotype	O
in	O
Chinese	O
patients	O
.	O

PS281	O
Our	O
findings	O
indicate	O
a	O
correlation	O
of	O
the	O
c	BG
.	IG
1569	IG
T	IG
-	IG
allele-13	IG
in	IG
XYLT	IG
-	IG
II-17	IG
with	O
an	O
earlier	O
manifestation	O
of	O
osteoarthritis-23	BP
and	O
that	O
the	O
serum	BG
XT-28	IG
activity	O
is	O
a	O
potential	O
biochemical	O
marker	O
for	O
staging	O
and	O
monitoring	O
the	O
progression	O
of	O
articular	O
cartilage	O
damage	O
in	O
osteoarthritis-46	BP
.	O

PS301	O
The	O
data	O
provide	O
strong	O
statistical	O
support	O
for	O
the	O
emerging	O
consensus	O
that	O
the	O
clinical	O
phenotype	O
in	O
spinal	BP
muscular	IP
atrophy-18	IP
is	O
directed	O
primarily	O
by	O
the	O
level	O
of	O
functional	O
SMN	BG
protein-28	IG
.	O

PS302	O
HDL	BG
-	IG
C-5	IG
has	O
emerged	O
as	O
an	O
important	O
independent	O
predictor	O
of	O
cardiovascular	BP
disease-15	IP
.	O

PS307	O
Identification	O
of	O
mutations	O
within	O
the	O
phenylalanine	BG
hydroxylase	IG
gene-8	IG
which	O
cause	O
phenylketonuria-11	BP
has	O
introduced	O
the	O
possibility	O
of	O
diagnosing	O
phenylketonuria	BP
by	O
direct	O
analysis	O
of	O
the	O
genome	O
.	O

PS311	O
An	O
out	O
-	O
of	O
-	O
frame	O
deletion	O
(	O
914	O
-	O
921del	O
)	O
was	O
identified	O
and	O
found	O
to	O
segregate	O
with	O
the	O
disease	O
,	O
further	O
highlighting	O
the	O
phenotypic	O
heterogeneity	O
of	O
lymphedema-29	BP
conditions	O
linked	O
to	O
FOXC2-33	BG
truncating	O
mutations	O
.	O

PS312	O
Cytochrome	BG
P450-2	IG
enzymes	O
have	O
been	O
linked	O
to	O
hypertension-8	BP
and	O
generation	O
of	O
reactive	O
oxygen	O
species	O
.	O

PS369	O
Mutations	O
in	O
myosin	BG
-	IG
binding	IG
protein	IG
C-7	IG
are	O
associated	O
with	O
mild	O
hypertrophy-12	BP
,	O
and	O
a	O
benign	O
prognosis	O
.	O

PS377	O
Classic	O
Wiskott	O
-	O
Aldrich	O
Syndrome	O
,	O
and	O
a	O
milder	O
form	O
,	O
X	O
-	O
linked	O
thrombocytopenia-15	BP
,	O
are	O
caused	O
by	O
mutations	O
of	O
the	O
Wiskott	BG
-	IG
Aldrich	IG
Syndrome	IG
protein-27	IG
gene	O
.	O

PS391	O
Somatic	O
mutations	O
in	O
PTPN11-4	BG
occur	O
in	O
35	O
%	O
of	O
patients	O
with	O
de	O
novo	O
,	O
nonsyndromic	O
juvenile	O
myelomonocytic	O
leukemia-18	BP
.	O

PS430	O
Mutations	O
in	O
the	O
human	O
ether	O
-	O
a	O
-	O
go	O
-	O
go	O
-	O
related	O
gene	O
(	O
KCNH2-28	BG
)	O
cause	O
the	O
chromosome	O
7	O
-	O
linked	O
LQT2	O
form	O
of	O
congenital	BP
Long	IP
QT-41	IP
syndrome	O
,	O
which	O
is	O
characterized	O
by	O
a	O
prolonged	O
QT	O
interval	O
and	O
a	O
bifid	O
T	O
-	O
wave	O
with	O
an	O
increased	O
susceptibility	O
to	O
life	BP
-	IP
threatening	IP
cardiac	IP
arrhythmias-67	IP
,	O
especially	O
in	O
children	O
.	O

PS436	O
Multiple	O
endocrine	O
neoplasia-3	BP
type	O
2	O
is	O
an	O
autosomal	O
dominant	O
tumour	O
syndrome	O
caused	O
by	O
germline	O
-	O
activating	O
mutations	O
of	O
the	O
RET	BG
proto	IG
-	IG
oncogene-23	IG
.	O

PS475	O
Spinal	BP
muscular	IP
atrophy-3	IP
is	O
a	O
common	O
autosomal	O
recessive	O
disorder	O
,	O
caused	O
by	O
homozygous	O
deletion	O
of	O
the	O
survival	BG
motor	IG
neuron	IG
gene	IG
1-21	IG
.	O

PS476	O
SMN2-1	BG
,	O
a	O
gene	O
highly	O
homologous	O
to	O
survival	BG
motor	IG
neuron	IG
gene	IG
1-12	IG
,	O
is	O
considered	O
to	O
influence	O
the	O
severity	O
of	O
Spinal	BP
muscular	IP
atrophy-23	IP
.	O

PS481	O
The	O
prognosis	O
of	O
MEN2-4	BG
is	O
linked	O
to	O
the	O
progression	O
of	O
medullary	O
thyroid	BP
carcinoma-13	IP
,	O
which	O
depends	O
mainly	O
on	O
the	O
stage	O
at	O
diagnosis	O
and	O
the	O
quality	O
of	O
initial	O
surgical	O
treatment	O
.	O

PS486	O
We	O
investigated	O
whether	O
mutations	O
in	O
the	O
PRSS1	BG
gene-8	IG
are	O
associated	O
with	O
hereditary	O
and	O
non	O
-	O
hereditary	O
pancreatitis-17	BP
.	O

PS511	O
HLA	BG
-	IG
DRB1	IG
*	IG
0405	IG
is	O
related	O
to	O
the	O
development	O
of	O
rheumatoid	BP
arthritis-13	IP
in	O
Taiwan	O
,	O
while	O
DRB1	BG
*-19	IG
0403	O
was	O
a	O
negative	O
risk	O
factor	O
.	O

PS517	O
MEN	BG
2-2	IG
gives	O
a	O
unique	O
model	O
for	O
early	O
prevention	O
and	O
cure	O
of	O
cancer-13	BP
and	O
for	O
stratified	O
roles	O
of	O
mutation	O
-	O
based	O
diagnosis	O
of	O
carriers	O
.	O

PS532	O
Severe	O
hypocholesterolemia-2	BP
coupled	O
with	O
normal	O
triglycerides	O
was	O
associated	O
with	O
low	O
LDL-11	BG
and	O
HDL	BG
-	IG
cholesterol-15	IG
,	O
as	O
well	O
as	O
with	O
low	O
apolipoproteins	O
A	O
-	O
I	O
and	O
B	O
.	O

PS554	O
We	O
have	O
defined	O
molecular	O
mechanisms	O
by	O
which	O
non	O
-	O
death	O
domain	O
FAS	O
mutations	O
result	O
in	O
reduced	O
lymphocyte	O
apoptosis	O
,	O
established	O
a	O
hierarchy	O
of	O
genotype	O
-	O
phenotype	O
correlation	O
among	O
mutation	O
-	O
positive	O
relatives	O
of	O
patients	O
with	O
autoimmune	BP
lymphoproliferative-37	IP
syndrome	O
,	O
and	O
demonstrated	O
that	O
FAS-43	BG
haploinsufficiency	O
can	O
lead	O
to	O
autoimmune	BP
lymphoproliferative-49	IP
syndrome	O
.	O

PS557	O
These	O
results	O
suggest	O
that	O
thymidylate	BG
synthaseER-6	IG
polymorphisms	O
do	O
not	O
predict	O
tumoral	BG
thymidylate	IG
synthase-13	IG
levels	O
possibly	O
depending	O
on	O
altered	O
thymidylate	BG
synthase-20	IG
regulation	O
in	O
cancer-23	BP
tissues	O
,	O
and	O
might	O
explain	O
the	O
lack	O
of	O
clear	O
correlation	O
with	O
clinical	O
outcome	O
after	O
chemotherapy	O
with	O
fluoropyrimidines	O
.	O

PS573	O
A	O
two	O
-	O
to	O
three	O
-	O
fold	O
increase	O
in	O
Lp	BG
(	IG
a	IG
)-13	IG
levels	O
in	O
patients	O
with	O
familial	BP
hypercholesterolaemia-19	IP
has	O
implied	O
that	O
low	O
-	BG
density	IG
lipoprotein	IG
receptor-27	IG
activity	O
may	O
be	O
an	O
important	O
factor	O
in	O
determining	O
plasma	O
Lp-37	BG
(	O
a	O
)	O
levels	O
,	O
as	O
it	O
is	O
in	O
determining	O
low	O
-	O
density	O
lipoprotein	O
cholesterol	O
concentration	O
.	O

PS582	O
Mutations	O
in	O
the	O
adenomatous	BG
polyposis	IG
coli	IG
gene-7	IG
are	O
responsible	O
for	O
the	O
disease	O
familial	O
adenomatous	O
polyposis-15	BP
,	O
a	O
dominantly	O
inherited	O
predisposition	O
to	O
colorectal	BP
cancer-23	IP
.	O

PS593	O
Hereditary	O
medullary	O
thyroid	BP
carcinoma-4	IP
is	O
caused	O
by	O
germline	O
mutations	O
of	O
the	O
RET	BG
proto	IG
-	IG
oncogene-15	IG
.	O

PS607	O
Wiskott	O
-	O
Aldrich	O
syndrome	O
and	O
X	O
-	O
linked	O
thrombocytopenia-15	BP
,	O
characterized	O
by	O
chronic	O
microthrombocytopenia-20	BP
with	O
and	O
without	O
immunodeficiency	O
,	O
are	O
caused	O
by	O
mutations	O
of	O
the	O
Wiskott	BG
-	IG
Aldrich	IG
syndrome	IG
protein	IG
gene-37	IG
.	O

PS623	O
Heterozygous	O
human	BG
CITED2	IG
mutation-4	IG
is	O
associated	O
with	O
congenital	BP
heart	IP
disease-10	IP
,	O
suggesting	O
haploinsufficiency	O
.	O

PS636	O
Our	O
result	O
suggest	O
that	O
the	O
135G	O
>	O
C	O
polymorphism	O
of	O
the	O
RAD51	BG
gene-13	IG
may	O
be	O
linked	O
to	O
endometrial	BP
cancer-19	IP
and	O
can	O
be	O
considered	O
as	O
an	O
additional	O
marker	O
of	O
this	O
disease	O
.	O

PS647	O
Residual	O
alpha	BG
-	IG
galactosidase	IG
A-5	IG
activity	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
neuropathic	BP
pain-14	IP
(	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
in	O
patients	O
with	O
mutations	O
leading	O
to	O
a	O
nonconservative	O
amino	O
acid	O
change	O
(	O
p	O
=	O
0	O
.	O
04	O
)	O
.	O

PS652	O
There	O
is	O
much	O
evidence	O
to	O
indicate	O
that	O
the	O
dopamine	BG
receptor	IG
D4-11	IG
gene	O
is	O
involved	O
in	O
psychiatric	BP
disorders-17	IP
.	O

PS657	O
Only	O
the	O
coincidence	O
of	O
GSTM1-5	BG
and	O
GSTT-7	BG
null	O
genotype	O
was	O
associated	O
with	O
oral	O
cavity	O
cancer-15	BP
.	O

PS658	O
X	O
-	O
linked	O
agammagobulinemia-4	BP
is	O
a	O
primary	O
immunodeficiency	O
disorder	O
caused	O
by	O
Bruton	O
'	O
s	O
tyrosine	BG
kinase-16	IG
gene	O
mutation	O
.	O

PS681	O
We	O
discuss	O
the	O
large	O
impact	O
of	O
RET	BG
proto	IG
-	IG
oncogene-10	IG
analysis	O
on	O
the	O
clinical	O
management	O
of	O
Multiple	O
endocrine	O
neoplasia-19	BP
type	O
2	O
and	O
the	O
role	O
of	O
early	O
RET	O
molecular	O
DNA	O
diagnosis	O
in	O
providing	O
clinicians	O
and	O
surgeons	O
with	O
valuable	O
information	O
that	O
enables	O
them	O
to	O
indicate	O
early	O
total	O
thyroidectomy	O
.	O

PS687	O
Inherited	O
disorders	O
of	O
fibrinogen-4	BG
affect	O
either	O
the	O
quantity	O
(	O
afibrinogenemia	O
and	O
hypofibrinogenemia-12	BP
)	O
or	O
the	O
quality	O
(	O
dysfibrinogenemia	O
)	O
of	O
the	O
circulating	O
fibrinogen-23	BG
or	O
both	O
(	O
hypodysfibrinogenemia	O
)	O
.	O

PS692	O
The	O
aims	O
of	O
this	O
study	O
were	O
(	O
1	O
)	O
to	O
describe	O
the	O
natural	O
history	O
of	O
pancreatitis-16	BP
associated	O
with	O
the	O
CFTR	BG
mutation-21	IG
,	O
(	O
2	O
)	O
to	O
look	O
for	O
genotype	O
-	O
phenotype	O
correlations	O
,	O
and	O
(	O
3	O
)	O
to	O
examine	O
the	O
frequency	O
of	O
CFTR-43	BG
mutations	O
in	O
a	O
population	O
of	O
patients	O
with	O
IP	O
.	O

PS712	O
Mutations	O
in	O
the	O
fibrillar	BG
collagen	IG
genes	IG
COL11A1-7	IG
and	O
COL11A2-9	BG
can	O
cause	O
sensorineural	BP
hearing	IP
loss-14	IP
associated	O
with	O
Stickler	O
syndrome	O
.	O

PS725	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
verify	O
a	O
possible	O
correlation	O
between	O
CYP1A1-13	BG
induction	O
,	O
MspI-16	BG
genotype	O
and	O
lung	BP
cancer-20	IP
incidence	O
.	O

PS728	O
the	O
only	O
positive	O
correlation	O
found	O
was	O
between	O
CYP1A1-8	BG
hyperinducibility	O
and	O
lung	O
cancer-12	BP
incidence	O
.	O

PS734	O
Variations	O
in	O
the	O
apolipoprotein	BG
E	IG
gene-6	IG
may	O
predict	O
the	O
incidence	O
of	O
coronary	BP
artery	IP
disease-14	IP
.	O

PS735	O
However	O
,	O
the	O
correlation	O
between	O
apolipoprotein	BG
E-7	IG
polymorphism	O
and	O
the	O
severity	O
of	O
coronary	BP
artery	IP
disease-15	IP
is	O
verified	O
.	O

PS736	O
Apolipoprotein	BG
E-2	IG
polymorphism	O
can	O
predict	O
coronary	BP
artery	IP
disease-8	IP
.	O

PS743	O
Expression	O
of	O
CHI3L1-3	BG
(	O
YKL	BG
-	IG
40-7	IG
)	O
has	O
been	O
correlated	O
with	O
prognosis	O
of	O
glioblastoma-15	BP
.	O

PS745	O
Patients	O
with	O
mutations	BG
near	IG
the	IG
5	IG
'	IG
terminus	IG
of	IG
the	IG
protein	IG
O	IG
-	IG
linked	IG
mannose	IG
beta1	IG
,	IG
2	IG
-	IG
N	IG
-	IG
acetylglucosaminyltransferase	IG
1-42	IG
coding	O
region	O
show	O
relatively	O
severe	O
brain	O
symptoms	O
such	O
as	O
hydrocephalus-52	BP
,	O
while	O
patients	O
with	O
mutations	BG
near	IG
the	IG
3	IG
'	IG
terminus	IG
have	O
milder	O
phenotypes	O
.	O

PS758	O
Cleidocranial	BP
dysplasia-2	IP
is	O
an	O
inherited	O
autosomal	O
-	O
dominant	O
skeletal	O
disease	O
caused	O
by	O
heterozygous	O
mutations	O
in	O
the	O
osteoblast	O
-	O
specific	O
transcription	O
factor	O
,	O
RUNX2-23	BG
.	O

PS763	O
Histopathological	O
analyses	O
were	O
previously	O
reported	O
in	O
two	O
hypofibrinogenemic	O
cases	O
with	O
discernible	O
hepatic	O
disease	O
,	O
revealing	O
that	O
both	O
underlying	O
mutations	O
(	O
gamma	BG
-	IG
Gly284Arg-23	IG
and	O
gamma	BG
-	IG
Arg375Trp-27	IG
)	O
were	O
associated	O
with	O
hepatic	O
fibrinogen	O
endoplasmic	BP
reticulum	IP
storage	IP
disease-37	IP
.	O

PS767	O
Homozygous	O
mutations	O
in	O
HAX1-4	BG
cause	O
an	O
autosomal	O
recessive	O
form	O
of	O
severe	O
congenital	BP
neutropenia-13	IP
.	O

PS793	O
Breast	BG
cancer	IG
susceptibility	G
gene	G
(	O
BRCA1-6	BG
)	O
is	O
known	O
to	O
be	O
responsible	O
for	O
hereditary	O
breast	O
and	O
ovarian	O
cancer-18	BP
.	O

PS821	O
Although	O
the	O
SLCO2A1	BG
gene-4	IG
is	O
only	O
the	O
second	O
gene	O
discovered	O
to	O
be	O
associated	O
with	O
Pachydermoperiostosis-15	BP
,	O
it	O
is	O
likely	O
to	O
be	O
a	O
major	O
cause	O
of	O
Pachydermoperiostosis-26	BP
in	O
the	O
Japanese	O
population	O
.	O

PS862	O
A	O
clear	O
correlation	O
between	O
the	O
phenotype	O
and	O
genotype	O
was	O
found	O
in	O
three	O
of	O
four	O
treated	O
farms	O
confirming	O
that	O
the	O
F1550I-20	BG
mutation	O
is	O
a	O
major	O
cause	O
of	O
synthetic	O
pyrethroid	BP
resistance-29	IP
in	O
Mexico	O
.	O

PS869	O
Polycythaemia-1	BP
vera	O
is	O
closely	O
associated	O
with	O
both	O
an	O
acquired	O
activating	O
mutation	O
of	O
the	O
JAK2	BG
tyrosine	IG
kinase-16	IG
in	O
granulocyte	O
-	O
derived	O
DNA	O
and	O
increased	BG
granulocyte	IG
polycythaemia	IG
rubra	IG
vera	IG
-	IG
1	IG
expression	IG
.	O

PS881	O
Mutations	O
of	O
the	O
cardiac	BG
beta	IG
-	IG
myosin	IG
heavy	IG
-	IG
chain-10	IG
gene	O
cause	O
hypertrophic	BP
cardiomyopathy-14	IP
.	O

PS886	O
Recent	O
studies	O
have	O
suggested	O
that	O
a	O
tumor	BG
suppressor	IG
gene-9	IG
located	O
in	O
the	O
region	O
3p21	O
-	O
26	O
of	O
chromosome	O
3	O
is	O
essential	O
to	O
the	O
genesis	O
of	O
sporadic	BP
renal	IP
cell	IP
carcinoma-29	IP
and	O
that	O
other	O
tumor	BG
suppressor	IG
genes-35	IG
located	O
on	O
other	O
chromosomes	O
may	O
be	O
involved	O
with	O
progression	O
of	O
this	O
malignancy-47	BP
.	O

PS900	O
This	O
study	O
validates	O
the	O
DFNB23	O
designation	O
and	O
supports	O
the	O
hypothesis	O
that	O
missense	BG
mutations	IG
in	IG
conserved	IG
motifs	IG
of	IG
PCDH15-18	IG
cause	O
nonsyndromic	BP
hearing	IP
loss-22	IP
.	O

PS903	O
Carrying	O
at	O
least	O
one	O
CYP1A1	BG
m1-6	IG
or	O
m2	BG
variant	IG
allele-10	IG
was	O
associated	O
with	O
a	O
decreased	BP
risk	IP
of	IP
endometrial	IP
cancer-19	IP
[	O
ORs	O
(	O
95	O
%	O
CIs	O
)	O
,	O
0	O
.	O
64	O
(	O
0	O
.	O
44	O
-	O
0	O
.	O
93	O
)	O
and	O
0	O
.	O
54	O
(	O
0	O
.	O
30	O
-	O
0	O
.	O
99	O
)	O
,	O
respectively	O
]	O
.	O

PS907	O
Mucopolysaccharidosis-1	BP
IIIA	O
(	O
Sanfilippo	O
syndrome	O
type	O
A	O
)	O
is	O
a	O
lysosomal	O
storage	O
disorder	O
caused	O
by	O
deficiency	O
of	O
the	O
enzyme	BG
sulfamidase-20	IG
.	O

PS918	O
Hereditary	O
hyperferritinemia	BP
-	IP
cataract	IP
syndrome-5	IP
is	O
an	O
autosomal	O
dominant	O
disorder	O
characterized	O
by	O
bilateral	O
cataracts	O
and	O
increased	O
serum	BG
L	IG
-	IG
ferritin-20	IG
,	O
in	O
the	O
absence	O
of	O
iron	O
overload	O
.	O

PS928	O
The	O
negative	O
association	O
of	O
tumor	BG
necrosis	IG
factora3	IG
-	IG
e1-9	IG
with	O
rheumatoid	BP
arthritis-12	IP
may	O
be	O
secondary	O
to	O
the	O
negative	O
linkage	O
disequilibrium	O
between	O
tumor	BG
necrosis	IG
factora3	IG
-	IG
e1-26	IG
and	O
HLA	BG
-	IG
DR4-30	IG
.	O

PS947	O
Inactivating	O
mutations	O
of	O
the	O
luteinizing	BG
hormoneR-6	IG
cause	O
Leydig	BP
cell	IP
hypoplasia	IP
in	O
males	O
while	O
that	O
of	O
the	O
follicle	BG
-	IG
stimulating	IG
hormoneR-20	IG
causes	O
hereditary	O
hypergonadotropic	BP
ovarian	IP
dysgenesis-25	IP
in	O
females	O
.	O

PS948	O
Severity	O
of	O
clinical	O
phenotype	O
in	O
Leydig	O
cell	O
hypoplasia-8	BP
correlates	O
with	O
the	O
amount	O
of	O
residual	O
activity	O
of	O
the	O
mutated	O
luteinizing	O
hormoneR-20	BG
.	O

PS949	O
Mutations	O
in	O
the	O
fibroblast	BG
growth	IG
factor	IG
receptor	IG
2-8	IG
cause	O
a	O
variety	O
of	O
craniosynostosis-13	BP
syndromes	O
.	O

PS961	O
Multivariate	O
logistic	O
regression	O
showed	O
that	O
only	O
an	O
intronic	BG
tagging	IG
SNP	IG
(	IG
rs4150351A	IG
/	IG
C	IG
)	IG
of	IG
Xeroderma	IG
pigmentosum	IG
group	IG
G-20	IG
/	IG
ERCC5-22	IG
was	O
associated	O
with	O
a	O
decreased	O
risk	O
of	O
squamous	BP
cell	IP
carcinoma-32	IP
of	O
the	O
head	O
and	O
neck	O
(	O
adjusted	O
odds	O
ratio	O
=	O
0	O
.	O
76	O
,	O
95	O
%	O
confidence	O
interval	O
=	O
0	O
.	O
62	O
-	O
0	O
.	O
92	O
for	O
AC	O
vs	O
.	O
AA	O
;	O
adjusted	O
odds	O
ratio	O
=	O
0	O
.	O
81	O
,	O
95	O
%	O
confidence	O
interval	O
=	O
0	O
.	O
67	O
-	O
0	O
.	O
98	O
for	O
AC	O
/	O
CC	O
vs	O
.	O
AA	O
)	O
,	O
but	O
this	O
association	O
was	O
nonsignificant	O
after	O
corrections	O
by	O
the	O
permutation	O
test	O
(	O
empirical	O
P	O
=	O
0	O
.	O
105	O
)	O
.	O

PS982	O
The	O
prognostic	O
significance	O
of	O
mutations	O
is	O
related	O
to	O
their	O
hypertrophic	O
expressivity	O
and	O
penetrance	O
,	O
with	O
the	O
exception	O
of	O
those	O
in	O
the	O
cardiac	O
troponin	BG
T-24	IG
,	O
which	O
are	O
associated	O
with	O
mild	O
hypertrophic	O
response	O
and	O
a	O
high	O
incidence	O
of	O
sudden	BP
cardiac	IP
death-40	IP
.	O

PS992	O
PIA2-1	BG
has	O
been	O
suggested	O
as	O
contributing	O
to	O
the	O
development	O
of	O
atherosclerosis-11	BP
via	O
coronary	O
plaque	O
rupture	O
and	O
thrombus	O
formation	O
.	O

PS1000	O
We	O
hypothesized	O
that	O
genetic	O
variants	O
of	O
the	O
HSPB1	BG
gene-9	IG
may	O
be	O
associated	O
with	O
lung	O
cancer-15	BP
susceptibility	O
and	O
survival	O
.	O

PS1005	O
In	O
conclusion	O
,	O
increased	O
plasma	BG
proteinase	IG
3-7	IG
and	O
high	O
expression	O
of	O
mproteinase	BG
3-13	IG
are	O
associated	O
with	O
small	O
vessel	O
vasculitis-19	BP
,	O
but	O
neither	O
of	O
them	O
is	O
a	O
consequence	O
of	O
the	O
564	O
A	O
/	O
G	O
polymorphism	O
of	O
the	O
proteinase	BG
3	IG
gene	IG
promotor-41	IG
.	O

PS1014	O
Germ	O
-	O
line	O
mutations	O
in	O
the	O
adenomatous	BG
polyposis	IG
coli	IG
gene-10	IG
are	O
responsible	O
for	O
familial	BP
adenomatous	IP
polyposis-16	IP
.	O

PS1027	O
ATM	BG
gene-2	IG
mutations	O
have	O
been	O
implicated	O
in	O
many	O
human	O
cancers-10	BP
.	O

PS1034	O
The	O
most	O
commonly	O
implicated	O
is	O
an	O
insertion	O
/	O
deletion	O
polymorphism	O
in	O
the	O
angiotensin	BG
-	IG
1	IG
converting	IG
enzyme	IG
1	IG
gene-19	IG
,	O
which	O
is	O
associated	O
with	O
the	O
risk	O
of	O
sudden	BP
cardiac	IP
death-30	IP
and	O
the	O
severity	O
of	O
hypertrophy	O
.	O

PS1047	O
MECP2	BG
gene-2	IG
mutations	O
may	O
be	O
considered	O
a	O
rare	O
cause	O
of	O
mental	BP
retardation-12	IP
in	O
males	O
although	O
great	O
phenotypic	O
variation	O
hinders	O
genotype	O
-	O
phenotype	O
correlation	O
.	O

PS1050	O
Steroid	BG
21	IG
-	IG
hydroxylase-4	IG
deficiency	O
(	O
21	O
-	O
OHD	O
)	O
is	O
the	O
most	O
common	O
cause	O
of	O
congenital	BP
adrenal	IP
hyperplasia-19	IP
.	O

PS1060	O
Included	O
in	O
the	O
deletion	O
interval	O
is	O
the	O
MEF2C	BG
gene-9	IG
that	O
usually	O
causes	O
severe	O
mental	BP
disability-15	IP
when	O
haploinsufficient	O
,	O
illustrating	O
the	O
complexity	O
of	O
clinic	O
-	O
cytogenetic	O
correlation	O
even	O
with	O
defined	BP
segmental	IP
aneuploidy-31	IP
.	O

PS1139	O
In	O
conclusion	O
,	O
this	O
study	O
strongly	O
suggests	O
that	O
two	O
lipoprotein	BG
lipase	IG
gene	IG
intronic	IG
variants-14	IG
may	O
be	O
associated	O
with	O
development	O
of	O
the	O
hypertension-22	BP
endophenotype	O
with	O
elevated	O
triglyceride	O
(	O
s	O
)	O
.	O

PS1146	O
Wiskott	O
-	O
Aldrich	O
syndrome	O
and	O
X	O
-	O
linked	O
thrombocytopenia-9	BP
are	O
caused	O
by	O
mutations	O
of	O
the	O
Wiskott	BG
-	IG
Aldrich	IG
syndrome	IG
protein	IG
gene-21	IG
which	O
encodes	O
a	O
502	BG
-	IG
amino	IG
acid	IG
protein	IG
,	O
named	O
Wiskott	BG
-	IG
Aldrich	IG
syndromeP	IG
.	O

PS1153	O
Multiple	O
endocrine	O
neoplasia-49	BP
type	O
1	O
is	O
caused	O
by	O
mutations	O
of	O
the	O
MEN1	BG
gene-59	IG
,	O
a	O
tumour	O
suppressor	O
gene	O
,	O
which	O
contains	O
one	O
untranslated	O
exon	O
and	O
nine	O
exons	O
.	O

PS1160	O
Ubiquinone	BG
oxydoreductase	IG
deficiency-14	IP
is	O
the	O
most	O
common	O
cause	O
of	O
respiratory	BP
chain-22	IP
defects	O
.	O

PS1173	O
Mutations	O
in	O
the	O
melanocortin	BG
-	IG
4	IG
receptor-7	IG
are	O
associated	O
with	O
early	O
-	O
onset	O
obesity-14	BP
in	O
humans	O
.	O

PS1174	O
Furthermore	O
,	O
a	O
null	BG
melanocortin	IG
-	IG
4	IG
receptor	IG
allele-9	IG
in	O
mice	O
leads	O
to	O
severe	O
obesity-15	BP
due	O
to	O
hyperphagia-18	BP
and	O
decreased	O
energy	O
expenditure	O
.	O

PS1192	O
A	O
significant	O
increase	O
in	O
IL	BG
-	IG
1beta	IG
+	IG
3953	IG
allele	IG
2-11	IG
frequency	O
was	O
found	O
in	O
patients	O
with	O
advanced	O
periodontitis-19	BP
compared	O
to	O
referent	O
subjects	O
(	O
the	O
Fisher	O
exact	O
test	O
;	O
p	O
=	O
0	O
.	O
013	O
)	O
.	O

PS1194	O
Heterozygous	O
germline	O
mutations	O
of	O
the	O
tumor	O
suppressor	O
gene	O
multiple	O
endocrine	BG
neoplasia	IG
type	IG
1-13	IG
are	O
responsible	O
for	O
multiple	BP
endocrine	IP
neoplasia	IP
type	IP
1-21	IP
,	O
a	O
dominantly	O
inherited	O
familial	O
cancer	O
syndrome	O
characterized	O
by	O
the	O
combined	O
occurrence	O
of	O
pituitary	BP
,	IP
parathyroid	IP
,	IP
and	IP
enteropancreatic	IP
tumors-41	IP
.	O

PS1197	O
Because	O
FGFR3-2	BG
and	O
PIK3CA	BG
mutations-5	IG
have	O
been	O
reported	O
to	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
seborrhoeic	O
keratosis-17	BP
,	O
we	O
analysed	O
whether	O
these	O
mutations	O
are	O
also	O
present	O
in	O
Stucco	O
keratosis	O
and	O
dermatosis	BP
papulosa	IP
nigra-33	IP
.	O

PS1204	O
In	O
transplant	O
recipients	O
who	O
did	O
not	O
lose	O
their	O
graft	O
during	O
the	O
first	O
3	O
years	O
after	O
transplantation	O
,	O
the	O
Gbeta3	BG
-	IG
TT	IG
genotype-22	IG
contributed	O
to	O
accelerated	O
loss	O
of	O
allograft	O
function	O
by	O
exaggeration	O
of	O
posttransplant	BP
hypertension-34	IP
.	O

PS1230	O
It	O
is	O
plausible	O
that	O
more	O
common	O
CDKN2A	BG
variants-8	IG
may	O
influence	O
both	O
melanoma-12	BP
susceptibility	O
and	O
nevus-15	BP
susceptibility	O
.	O

PS1236	O
Cytochrome	BG
P450	IG
1B1	IG
gene-25	IG
mutations	O
were	O
correlated	O
with	O
both	O
the	O
degree	O
of	O
angle	BP
dysgenesis-35	IP
and	O
the	O
patient	O
'	O
s	O
disease	O
severity	O
(	O
age	O
at	O
diagnosis	O
,	O
difficulty	O
in	O
achieving	O
intraocular	O
pressure	O
control	O
)	O
.	O

PS1237	O
Mucopolysaccharidosis-1	BP
IVA	O
is	O
a	O
lysosomal	O
storage	O
disorder	O
caused	O
by	O
the	O
deficiency	O
of	O
N	BG
-	IG
acetylgalactosamine	IG
-	IG
6	IG
-	IG
sulfate	IG
sulfatase-20	IG
(	O
GALNS-22	BG
)	O
.	O

PS1249	O
The	O
MDR1	BG
variant	IG
C3435T-4	IG
was	O
associated	O
with	O
disease	O
behavior	O
in	O
CD	O
(	O
OR	O
=	O
1	O
.	O
45	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
01	O
-	O
2	O
.	O
08	O
,	O
P	O
=	O
0	O
.	O
04	O
)	O
,	O
whereas	O
the	O
SNP	BG
rs3789243-41	IG
was	O
found	O
to	O
be	O
associated	O
with	O
pancolitis-48	BP
in	O
UC	O
patients	O
(	O
OR	O
=	O
1	O
.	O
35	O
,	O
CI	O
=	O
1	O
.	O
00	O
-	O
1	O
.	O
82	O
,	O
P	O
=	O
0	O
.	O
05	O
)	O
.	O

PS1254	O
Additionally	O
,	O
cyclin	BG
-	IG
dependent	IG
kinase	IG
-	IG
like	IG
5	IG
gene-10	IG
mutations	O
have	O
recently	O
been	O
described	O
in	O
7	O
males	O
with	O
a	O
more	O
severe	O
epileptic	O
encephalopathy-24	BP
and	O
a	O
worse	O
outcome	O
compared	O
to	O
female	O
patients	O
.	O

PS1257	O
p63-1	BG
mutations	O
have	O
been	O
associated	O
with	O
EEC	O
syndrome	O
(	O
ectrodactyly	BP
,	O
ectodermal	BP
dysplasia-13	IP
,	O
and	O
cleft	BP
lip	IP
/	IP
palate	IP
)	O
,	O
as	O
well	O
as	O
with	O
nonsyndromic	BP
split	IP
hand	IP
-	IP
split	IP
foot	IP
malformation	IP
(	O
SHFM	BP
)	O
.	O

PS1271	O
A	O
haplotype	O
that	O
located	O
CCL3-5	BG
on	O
chromosome	O
17q12	O
had	O
significant	O
correlation	O
with	O
Rheumatoid	BP
arthritis-14	IP
(	O
P	O
=	O
7	O
.	O
56E	O
-	O
05	O
)	O
,	O
and	O
the	O
global	O
similarity	O
score	O
of	O
CCL3-31	BG
was	O
ranked	O
in	O
the	O
top	O
of	O
all	O
Rheumatoid	O
arthritis	O
-	O
related	O
genes	O
,	O
excluding	O
known	O
susceptibility	O
genes	O
(	O
P	O
=	O
8	O
.	O
42E	O
-	O
07	O
)	O
.	O

PS1274	O
Intriguingly	O
,	O
the	O
association	O
between	O
growth	BG
hormone1-7	IG
promoter	O
haplotype	O
and	O
risk	O
of	O
hypertension-13	BP
was	O
much	O
greater	O
in	O
females	O
than	O
in	O
males	O
.	O

PS1278	O
However	O
,	O
an	O
association	O
between	O
growth	BG
hormoneRd3-7	IG
genotype	O
and	O
hypertension-10	BP
was	O
observed	O
among	O
stroke-14	BP
patients	O
,	O
particularly	O
females	O
.	O

PS1296	O
These	O
results	O
suggest	O
that	O
decreased	O
mRNA	O
levels	O
of	O
DISC1-9	BG
expression	O
,	O
associating	O
with	O
the	O
risk	O
haplotype	O
,	O
may	O
be	O
implicated	O
in	O
the	O
pathophysiology	O
of	O
bipolar	BP
disorder-26	IP
.	O

PS1301	O
In	O
multiple	O
linear	O
regression	O
analysis	O
,	O
waist	O
circumference	O
(	O
beta	O
=	O
0	O
.	O
024	O
,	O
P	O
=	O
0	O
.	O
000	O
)	O
and	O
family	O
history	O
of	O
hypertension-26	BP
(	O
beta	O
=	O
0	O
.	O
467	O
,	O
P	O
=	O
0	O
.	O
000	O
)	O
were	O
significant	O
independent	O
predictors	O
for	O
homeostasis	O
model	O
assessment	O
of	O
insulin	BG
resistance-50	IP
,	O
and	O
triglyceride	O
(	O
beta	O
=	O
0	O
.	O
328	O
,	O
P	O
=	O
0	O
.	O
007	O
)	O
and	O
family	O
history	O
of	O
hypertension-71	BP
(	O
beta	O
=	O
0	O
.	O
395	O
,	O
P	O
=	O
0	O
.	O
016	O
)	O
were	O
significant	O
independent	O
predictors	O
for	O
soluble	O
intercellular	BG
adhesion	IG
molecule	IG
-	IG
1-95	IG
.	O

PS1308	O
Progressive	O
familial	O
intrahepatic	BP
cholestasis-4	IP
,	O
an	O
inherited	O
liver	O
disease	O
of	O
childhood	O
,	O
is	O
characterized	O
by	O
cholestasis	O
and	O
either	O
normal	O
or	O
increased	O
serum	BG
gamma	IG
-	IG
glutamyltransferase-25	IG
activity	O
.	O

PS1312	O
Mutations	O
in	O
the	O
MLC1	BG
gene-5	IG
cause	O
megalencephalic	O
leukoencephalopathy-8	BP
with	O
subcortical	O
cysts	O
.	O

PS1315	O
No	O
correlation	O
was	O
found	O
between	O
Cyclooxygenase	BG
-	IG
2-8	IG
diplotypes	O
and	O
clinical	O
characteristics	O
of	O
inflammatory	BP
bowel	IP
disease-16	IP
.	O

PS1329	O
Several	O
previous	O
studies	O
have	O
found	O
that	O
the	O
presence	O
of	O
the	O
PON1R192	BG
allele-12	IG
raises	O
the	O
risk	O
of	O
cardiovascular	BP
disease-18	IP
while	O
others	O
found	O
no	O
correlation	O
.	O

PS1331	O
Multiple	O
osteochondromas-2	BP
is	O
genetically	O
heterogeneous	O
and	O
is	O
associated	O
with	O
mutations	O
in	O
the	O
EXT1-13	BG
and	O
EXT2	BG
genes-16	IG
.	O

PS1359	O
Reversion	O
of	O
fumarylacetoacetate	BG
hydrolase	IG
mutant	IG
alleles-6	IG
in	O
livers	O
of	O
Hereditary	BP
tyrosinemia-11	IP
type	O
I	O
patients	O
was	O
reported	O
previously	O
,	O
but	O
the	O
clinical	O
significance	O
of	O
this	O
phenomenon	O
has	O
not	O
been	O
fully	O
documented	O
.	O

PS1366	O
Cerebral	O
autosomal	O
dominant	O
arteriopathy-4	BP
with	O
subcortical	BP
infarcts-7	IP
and	O
leukoencephalopathy-9	BP
is	O
associated	O
with	O
arterial	O
smooth	O
muscle	O
degeneration	O
linked	O
to	O
mutations	BG
in	IG
the	IG
Notch3	IG
gene-23	IG
,	O
whose	O
product	O
is	O
a	O
transmembrane	O
receptor	O
that	O
functions	O
in	O
cell	O
-	O
cell	O
communication	O
.	O

PS1377	O
Inactivating	O
mutations	O
of	O
FSH	BG
receptor	IG
gene-6	IG
,	O
in	O
women	O
,	O
are	O
associated	O
with	O
primary	BP
ovarian	IP
insufficiency-16	IP
.	O

PS1379	O
Polymorphisms	O
in	O
EGLN2-3	BG
may	O
facilitate	O
cancer-6	BP
cell	O
survival	O
under	O
hypoxic	O
conditions	O
and	O
directly	O
associate	O
with	O
cancer-16	BP
susceptibility	O
.	O

PS1384	O
The	O
GG	BG
genotype-3	IG
was	O
associated	O
with	O
a	O
lower	O
risk	O
of	O
Osteoarthritis-11	BP
development	O
of	O
the	O
knee	O
;	O

PS1399	O
These	O
associations	O
indicate	O
that	O
hemoglobin	BG
C-6	IG
reduces	O
parasitemia-8	BP
and	O
confers	O
protection	O
against	O
mild	O
malaria	O
attack	O
.	O

PS1400	O
Hyperhomocystinemia-1	BP
detected	O
in	O
children	O
with	O
a	O
parental	O
history	O
of	O
premature	O
coronary	O
disease	O
is	O
associated	O
with	O
the	O
TT	BG
genotype	IG
of	IG
methylenetetrahydrofolate	IG
reductase-21	IG
and	O
with	O
low	O
folate	O
levels	O
.	O

PS1402	O
Mutations	O
in	O
the	O
retina	BG
-	IG
specific	IG
ABC	IG
transporter-8	IG
gene	O
are	O
responsible	O
for	O
autosomal	BP
recessive	IP
Stargardt	IP
disease-16	IP
.	O

PS1405	O
These	O
demonstrated	O
that	O
the	O
degree	O
of	O
correlation	O
between	O
Cystic	BG
fibrosisTR	IG
genotype-11	IG
and	O
Cystic	BP
fibrosis-14	IP
phenotype	O
varies	O
between	O
its	O
clinical	O
components	O
and	O
is	O
highest	O
for	O
the	O
pancreatic	O
status	O
and	O
lowest	O
for	O
pulmonary	O
disease	O
.	O

PS1411	O
Elevated	O
factor	BG
VII-3	IG
level	O
is	O
a	O
risk	O
factor	O
for	O
coronary	BP
artery	IP
disease-12	IP
.	O

PS1414	O
Mutations	O
causing	O
total	O
absence	O
of	O
serum	BG
Alpha	IG
-	IG
1	IG
antitrypsin-10	IG
(	O
Null	O
mutations	O
)	O
were	O
suggested	O
to	O
be	O
associated	O
with	O
very	O
early	O
onset	O
emphysema-24	BP
but	O
their	O
clinical	O
phenotype	O
is	O
poorly	O
known	O
.	O

PS1436	O
episodic	BP
ataxia-2	IP
type	IP
1	IP
is	O
due	O
to	O
a	O
mutation	BG
in	IG
KCNA1-11	IG
,	O
the	O
gene	O
encoding	O
human	O
Kv1	O
.	O
1	O
on	O
chromosome	O
12p13	O
,	O
which	O
contributes	O
as	O
a	O
subunit	O
to	O
the	O
formation	O
of	O
potassium	O
channels	O
in	O
motor	O
nerve	O
terminals	O
and	O
in	O
many	O
central	O
nervous	O
system	O
neurones	O
.	O

PS1446	O
For	O
sulphadoxine	O
-	O
pyrimethamine	O
the	O
dhfr	O
single	O
(	O
S108N	O
)	O
(	O
Day	O
28	O
,	O
odds	O
ratio	O
=	O
3	O
.	O
5	O
[	O
95	O
%	O
CI	O
:	O
1	O
.	O
9	O
-	O
6	O
.	O
3	O
]	O
)	O
and	O
triple	O
mutants	O
(	O
S108N	O
,	O
N51I	O
,	O
C59R	O
)	O
(	O
Day	O
28	O
,	O
odds	O
ratio	O
=	O
3	O
.	O
1	O
[	O
95	O
%	O
CI	O
:	O
2	O
.	O
0	O
-	O
4	O
.	O
9	O
]	O
)	O
and	O
dhfr	BG
-	IG
dhps	IG
quintuple	IG
mutants-74	IG
(	O
Day	O
28	O
,	O
odds	O
ratio	O
=	O
5	O
.	O
2	O
[	O
95	O
%	O
CI	O
:	O
3	O
.	O
2	O
-	O
8	O
.	O
8	O
]	O
)	O
also	O
increased	O
the	O
risk	O
of	O
treatment	BP
failure-105	IP
.	O

PS1450	O
Mutations	O
of	O
the	O
peripherin	BG
/	IG
RDS	IG
gene-7	IG
have	O
been	O
reported	O
in	O
several	O
kinds	O
of	O
retinal	BP
dystrophy-16	IP
,	O
and	O
they	O
show	O
a	O
variety	O
of	O
manifestations	O
.	O

PS1452	O
Novel	O
chymotrypsin	BG
C	IG
gene-4	IG
variations	O
and	O
haplotypes	O
are	O
associated	O
with	O
chronic	O
pancreatitis-12	BP
in	O
a	O
Chinese	O
population	O
.	O

PS1464	O
Ullrich	O
congenital	BP
muscular	IP
dystrophy-4	IP
is	O
caused	O
by	O
recessive	O
and	O
dominant	O
mutations	O
in	O
COL6A	BG
genes-14	IG
.	O

PS1506	O
familial	O
defective	O
apolipoprotein	BG
B	IG
-	IG
100-6	IG
appears	O
to	O
be	O
a	O
significant	O
genetic	O
cause	O
of	O
hypercholesterolemia-15	BP
in	O
Belgium	O
.	O

PS1508	O
Inactivating	O
mutations	BG
of	IG
the	IG
calcium	IG
-	IG
sensing	IG
receptor	IG
,	O
a	O
G	O
-	O
protein	O
-	O
coupled	O
receptor	O
with	O
extracellular	O
(	O
ECD	O
)	O
,	O
transmembrane	O
(	O
TMD	O
)	O
and	O
intracellular	O
(	O
ICD	O
)	O
domains	O
,	O
cause	O
familial	O
hypocalciuric	BP
hypercalcaemia-37	IP
,	O
neonatal	BP
severe	IP
primary	IP
hyperparathyroidism-42	IP
and	O
occasionally	BP
primary	IP
hyperparathyroidism-46	IP
in	O
adults	O
.	O

PS1514	O
Mucopolysaccharidosis-1	BP
VII	O
is	O
an	O
autosomal	O
recessive	O
disorder	O
caused	O
by	O
a	O
deficiency	O
of	O
beta	BG
-	IG
glucuronidase-15	IG
.	O

PS1528	O
Mutations	O
in	O
the	O
ATR	BG
-	IG
X	IG
gene-7	IG
that	O
encodes	O
a	O
putative	O
global	O
transcription	O
factor	O
have	O
been	O
identified	O
in	O
patients	O
with	O
ATR	O
-	O
X	O
as	O
well	O
as	O
those	O
with	O
other	O
forms	O
of	O
X	O
-	O
linked	O
mental	BP
retardation-36	IP
syndrome	O
.	O

PS1548	O
This	O
study	O
provides	O
additional	O
evidence	O
that	O
the	O
amount	O
of	O
laminin	BG
alpha2-11	IG
is	O
most	O
critical	O
for	O
the	O
prevention	O
of	O
muscular	BP
dystrophy-20	IP
.	O

PS1554	O
Familial	BP
Multiple	IP
endocrine	IP
neoplasia	IP
1-5	IP
is	O
defined	O
by	O
one	O
first	O
-	O
degree	O
relative	O
having	O
at	O
least	O
one	O
of	O
these	O
3	O
main	O
tumors	O
,	O
and	O
is	O
associated	O
with	O
germline	BG
mutations	IG
in	IG
the	IG
Multiple	IG
endocrine	IG
neoplasia	IG
1	IG
gene	IG
on	O
11q13	O
in	O
a	O
large	O
proportion	O
of	O
cases	O
.	O

PS1582	O
Spinal	BP
muscular	IP
atrophy-3	IP
is	O
a	O
recessive	O
neuromuscular	O
disorder	O
caused	O
by	O
loss	O
of	O
the	O
SMN1	BG
gene-15	IG
.	O

PS1593	O
Juvenile	O
open	O
-	O
angle	O
glaucoma-5	BP
has	O
been	O
found	O
to	O
be	O
associated	O
with	O
molecular	O
defects	O
in	O
the	O
myocilin	BG
gene-18	IG
.	O

PS1606	O
CAG	BG
repeat	IG
expansions	IG
with	IG
loss	IG
of	IG
CAT-7	IG
interruptions	IG
in	O
the	O
coding	O
region	O
of	O
the	O
ataxin	O
-	O
1	O
gene-18	O
are	O
associated	O
with	O
spinocerebellar	BP
ataxia	IP
type	IP
1	IP
.	O

PS1612	O
Respiratory	BP
failure-2	IP
in	O
the	O
course	O
of	O
Chronic	O
obstructive	O
pulmonary	O
disease	O
also	O
correlates	O
with	O
lower	O
expression	O
of	O
manganese	BG
superoxide	IG
dismutase	IG
mRNA-20	IG
.	O

PS1615	O
Microarrays	O
demonstrated	O
increased	O
expression	O
of	O
SPARC-6	BG
,	O
along	O
with	O
other	O
extracellular	O
matrix	O
genes	O
,	O
in	O
systemic	BP
sclerosis	IP
patients	IP
compared	O
with	O
normal	O
controls	O
.	O

PS1616	O
Systemic	O
sclerosis-25	BP
fibroblasts	O
also	O
had	O
increased	O
SPARC	BG
protein-31	IG
levels	O
.	O

PS1617	O
This	O
study	O
is	O
the	O
first	O
to	O
show	O
that	O
polymorphisms	O
of	O
the	O
SPARC	BG
gene-13	IG
are	O
associated	O
with	O
susceptibility	O
to	O
,	O
and	O
clinical	O
manifestations	O
of	O
,	O
systemic	O
sclerosis-26	BP
and	O
that	O
they	O
may	O
also	O
be	O
functionally	O
important	O
in	O
influencing	O
SPARC-37	BG
expression	O
in	O
skin	O
fibroblasts	O
.	O

PS1620	O
However	O
,	O
in	O
the	O
validation	O
set	O
,	O
only	O
miR	BG
-	IG
30c	IG
-	IG
1	IG
rs928508-14	IG
was	O
consistently	O
an	O
non	O
-	O
small	O
cell	O
lung	O
cancer-23	BP
survival	O
predictor	O
and	O
the	O
protective	O
role	O
of	O
rs928508	BG
AG-32	IG
/	O
GG-34	BG
genotypes	O
was	O
more	O
pronounced	O
among	O
early	O
-	O
stage	O
(	O
stage	O
I	O
/	O
II	O
)	O
patients	O
and	O
patients	O
treated	O
with	O
surgery	O
.	O

PS1627	O
While	O
classical	O
congenital	BP
muscular	IP
dystrophy-5	IP
with	O
white	O
matter	O
abnormality	O
is	O
the	O
commonest	O
phenotype	O
associated	O
with	O
laminin	BG
alpha2-17	IG
deficiency	O
,	O
12	O
%	O
of	O
reported	O
cases	O
have	O
later	O
onset	O
,	O
slowly	BP
progressive	IP
weakness-31	IP
more	O
accurately	O
designated	O
limb	BP
-	IP
girdle	IP
muscular	IP
dystrophy-39	IP
.	O

PS1630	O
Thus	O
,	O
any	O
mutation	O
in	O
SMAD4-6	BG
can	O
cause	O
Juvenile	O
polyposis	O
-	O
hemorrhagic	O
telangiectasia-13	BP
.	O

PS1652	O
Mutations	O
in	O
lamin	BG
A	IG
/	IG
C	IG
gene-7	IG
cause	O
a	O
severe	O
and	O
progressive	O
dilated	BP
cardiomyopathy-14	IP
in	O
a	O
relevant	O
proportion	O
of	O
patients	O
.	O

PS1654	O
Mutations	O
in	O
the	O
receptor	BG
expression	IG
enhancing	IG
protein	IG
1-8	IG
gene	O
have	O
recently	O
been	O
reported	O
to	O
be	O
associated	O
with	O
an	O
autosomal	BP
dominant	IP
hereditary	IP
spastic	IP
paraplegias	IP
phenotype	IP
(	O
SPG31	BP
)	O
.	O

PS1662	O
We	O
concluded	O
that	O
Insulin	BG
-	IG
like	IG
growth	IG
factor	IG
-	IG
axis	IG
gene	IG
variants-12	IG
are	O
associated	O
with	O
clinical	O
outcomes	O
in	O
pancreatic	BP
cancer-20	IP
.	O

PS1667	O
Amplifications	O
of	O
epidermal	BG
growth	IG
factor	IG
receptor-6	IG
were	O
found	O
only	O
in	O
the	O
squamous	O
cell	O
cancers-14	BP
.	O

PS1684	O
All	O
three	O
clinical	O
subtypes	O
of	O
Spinal	BP
muscular	IP
atrophy-8	IP
are	O
caused	O
by	O
mutations	O
of	O
the	O
SMN1	BG
gene-16	IG
.	O

PS1719	O
We	O
found	O
that	O
the	O
CYP2C19	BG
genotype-6	IG
affects	O
diazepam	O
pharmacokinetics	O
and	O
emergence	O
from	O
general	O
anesthesia-14	BP
and	O
that	O
the	O
slow	O
-	O
emergence	O
group	O
possesses	O
lower	O
levels	O
of	O
CYP3A4-26	BG
messenger	O
ribonucleic	O
acid	O
than	O
are	O
found	O
in	O
the	O
rapid	O
-	O
emergence	O
group	O
.	O

PS1729	O
Occasionally	O
MEN	O
2A	O
or	O
familial	O
medullary	O
thyroid	BP
carcinoma-8	IP
occurs	O
in	O
association	O
with	O
HSCR1-13	BG
,	O
albeit	O
with	O
low	O
penetrance	O
.	O

PS1730	O
The	O
predisposing	O
RET	BG
mutation-4	IG
in	O
all	O
seven	O
families	O
had	O
been	O
previously	O
reported	O
in	O
MEN	O
2A	O
or	O
familial	O
medullary	O
thyroid	BP
carcinoma-20	IP
and	O
occurred	O
in	O
exon	O
10	O
at	O
codons	O
609	O
,	O
618	O
or	O
620	O
,	O
resulting	O
in	O
C609Y	O
,	O
C618S	O
,	O
C620R	O
or	O
C620W	O
substitution	O
.	O

PS1751	O
The	O
present	O
data	O
provide	O
in	O
vivo	O
evidence	O
that	O
SCA2-9	BG
and	O
SCA3-11	BG
lead	O
to	O
distinct	O
patterns	O
of	O
brain	BP
atrophy-18	IP
,	O
while	O
the	O
atrophy	O
changes	O
in	O
SCA1-25	BG
overlap	O
with	O
both	O
SCA2-29	BG
and	O
SCA3-31	BG
.	O

PS1754	O
There	O
is	O
no	O
bleeding	O
associated	O
with	O
Factor	BG
XII	IG
deficiency-9	IP
,	O
but	O
Factor	BG
XII	IG
deficiency-14	IP
has	O
been	O
reported	O
to	O
be	O
associated	O
with	O
risk	O
of	O
thrombosis-24	BP
in	O
some	O
studies	O
.	O

PS1763	O
Adult	O
mastocytosis-2	BP
is	O
an	O
incurable	O
clonal	O
disease	O
associated	O
with	O
c	BG
-	IG
KIT	IG
mutations-13	IG
,	O
mostly	O
in	O
exon	O
17	O
(	O
D816V	O
)	O
.	O

PS1767	O
Metachromatic	BP
Leukodystrophy-2	IP
is	O
a	O
rare	O
inherited	O
lysosomal	O
storage	O
disorder	O
caused	O
by	O
the	O
deficiency	O
of	O
Arylsulfatase	BG
A-16	IG
.	O

PS1773	O
PvuII-1	BG
and	O
XbaI-3	BG
polymorphisms	O
of	O
the	O
ER	BG
(	IG
alpha	IG
)	IG
gene-11	IG
were	O
associated	O
with	O
bone	O
mineral	O
density-17	BP
in	O
postmenopausal	O
Japanese	O
women	O
.	O

PS1777	O
In	O
this	O
Chinese	O
family	O
an	O
R555Q	O
mutation	O
of	O
the	O
TGFBI	BG
gene-11	IG
was	O
associated	O
with	O
Reis	BP
-	IP
Bucklers	IP
corneal	IP
dystrophy-19	IP
.	O

PS1779	O
Mutations	O
in	O
the	O
BRCA1	BG
gene-5	IG
,	O
discovered	O
in	O
1994	O
,	O
are	O
associated	O
with	O
an	O
80	O
-	O
90	O
%	O
lifetime	O
risk	O
of	O
breast	BP
cancer-23	IP
.	O

PS1784	O
Mutations	O
in	O
the	O
lamin	BG
A	IG
/	IG
C	IG
gene-8	IG
are	O
established	O
causes	O
of	O
familial	O
dilated	BP
cardiomyopathy-15	IP
with	O
atrio	O
-	O
ventricular	O
block	O
although	O
relatively	O
little	O
is	O
known	O
about	O
genotype	O
-	O
phenotype	O
correlations	O
.	O

PS1801	O
HLA	BG
-	IG
DQB1	IG
*	IG
02-5	IG
alleles	O
were	O
associated	O
with	O
multiple	O
sclerosis-11	BP
.	O

PS1820	O
This	O
disorder	O
was	O
regarded	O
as	O
a	O
separate	O
disease	O
until	O
the	O
identification	O
of	O
the	O
APC	BG
gene-15	IG
when	O
it	O
was	O
recognized	O
that	O
mutations	O
in	O
the	O
APC	BG
gene-25	IG
were	O
the	O
underlying	O
cause	O
of	O
both	O
Gardner	O
syndrome	O
and	O
familial	O
adenomatous	O
polyposis-37	BP
.	O

PS1823	O
Multiple	O
endocrine	O
neoplasia-3	BP
type	O
1	O
is	O
caused	O
by	O
germline	O
mutations	O
of	O
the	O
multiple	O
endocrine	BG
neoplasia	IG
type	IG
1	IG
tumor	IG
suppressor	IG
gene-20	IG
.	O

PS1838	O
WNK4	BG
gene-2	IG
is	O
well	O
correlated	O
with	O
essential	O
hypertension-8	BP
.	O

PS1845	O
In	O
addition	O
,	O
dysregulation	O
of	O
HOXD	BG
gene	IG
cluster-8	IG
has	O
been	O
proposed	O
to	O
account	O
for	O
the	O
limb	BP
abnormalities-17	IP
in	O
patients	O
with	O
chromosome	O
2q	O
rearrangements	O
.	O

PS1856	O
Mutation	O
spectrum	O
of	O
phenylalanine	BG
hydroxylase-5	IG
gene	O
in	O
patients	O
with	O
phenylketonuria-10	BP
in	O
Northern	O
China	O
is	O
described	O
with	O
a	O
discussion	O
on	O
genotype	O
-	O
phenotype	O
correlation	O
.	O

PS1858	O
In	O
a	O
previous	O
report	O
,	O
we	O
identified	O
several	O
heterozygous	O
alterations	O
,	O
including	O
a	O
complete	O
deletion	O
,	O
of	O
the	O
proline	BG
dehydrogenase-20	IG
gene	O
,	O
which	O
were	O
associated	O
with	O
moderate	O
hyperprolinemia-28	BP
in	O
a	O
subset	O
of	O
DSM	O
III	O
schizophrenic	O
patients	O
.	O

PS1881	O
Multiple	O
endocrine	O
neoplasia-3	BP
type	O
2	O
is	O
an	O
autosomal	O
-	O
dominant	O
hereditary	O
cancer-12	BP
syndrome	O
caused	O
by	O
missense	O
gain	O
-	O
of	O
-	O
function	O
mutations	O
of	O
the	O
rearranged	O
during	O
transfection	O
proto	O
-	O
oncogene	O
,	O
which	O
encodes	O
the	O
receptor	BG
tyrosine	IG
kinase-37	IG
,	O
on	O
chromosome	O
10	O
.	O

PS1887	O
A	O
new	O
polymorphism	O
(	O
c	O
.	O
488	O
C	O
>	O
T	O
)	O
in	O
the	O
PRSS1	BG
gene-15	IG
is	O
associated	O
with	O
chronic	O
pancreatitis-20	BP
,	O
but	O
it	O
did	O
not	O
affect	O
the	O
clinical	O
phenotype	O
while	O
the	O
A121T	BG
(	IG
c	IG
.	IG
361	IG
G	IG
>	IG
A	IG
)	IG
mutation	IG
in	IG
the	IG
gene	IG
shows	O
a	O
significant	O
correlation	O
in	O
the	O
patients	O
with	O
hereditary	BP
pancreatitis-54	IP
.	O

PS1900	O
However	O
,	O
XPF	BG
-	IG
rs1799801-5	IG
may	O
be	O
associated	O
with	O
cancer-10	BP
risk	O
in	O
Caucasian	O
populations	O
,	O
which	O
needs	O
to	O
be	O
further	O
validated	O
in	O
single	O
large	O
,	O
well	O
-	O
designed	O
prospective	O
studies	O
.	O

PS1908	O
In	O
addition	O
,	O
PTEN-4	BG
was	O
identified	O
as	O
the	O
susceptibility	O
gene	O
for	O
two	O
hamartoma	BP
syndromes	IP
:	O
Cowden	BP
disease	IP
and	O
Bannayan	BP
-	IP
Zonana	IP
(	IP
BZS	IP
)	IP
or	IP
Ruvalcaba	IP
-	IP
Riley	IP
-	IP
Smith	IP
syndrome	IP
.	O

PS1928	O
Thus	O
,	O
manifestations	O
attributable	O
to	O
this	O
deletion	O
are	O
reduced	O
weight	O
for	O
height	O
,	O
minor	BP
facial	IP
anomalies	IP
,	O
ADHD	O
and	O
some	O
learning	O
and	O
fine	O
motor	O
deficiencies	O
,	O
while	O
seizures-28	BP
may	O
be	O
associated	O
with	O
deletions	O
of	O
LETM1-35	BG
.	O

PS1929	O
Several	O
oncogenes	O
and	O
tumor	BG
-	IG
suppressor	IG
genes-7	IG
have	O
been	O
shown	O
to	O
be	O
implicated	O
in	O
the	O
development	O
,	O
progression	O
and	O
response	O
to	O
therapy	O
of	O
invasive	O
breast	BP
cancer-26	IP
.	O

PS1942	O
One	O
form	O
of	O
autosomal	O
recessive	O
Hereditary	O
spastic	BP
paraplegia-8	IP
(	O
on	O
chromosome	O
16	O
)	O
is	O
due	O
to	O
mutations	O
in	O
the	O
paraplegin	BG
gene-21	IG
,	O
which	O
encodes	O
a	O
mitochondrial	O
protein	O
homologous	O
to	O
metalloproteases	O
.	O

PS1943	O
One	O
form	O
of	O
X	O
-	O
linked	O
Hereditary	O
spastic	BP
paraplegia-9	IP
is	O
caused	O
by	O
mutations	O
in	O
the	O
proteolipoprotein	BG
gene-17	IG
,	O
an	O
intrinsic	O
myelin	O
protein	O
.	O

PS1944	O
X	O
-	O
linked	O
spastic	BP
paraplegia-5	IP
can	O
be	O
caused	O
also	O
by	O
mutations	O
in	O
the	O
L1CAM	BG
gene-15	IG
.	O

PS1964	O
Thrombin-1	BG
generation	O
assay	O
may	O
serve	O
as	O
a	O
quick	O
tool	O
for	O
confirming	BP
severe	IP
deficiency-13	IP
until	O
the	O
specific	O
mutation	O
is	O
identified	O
.	O

PS1975	O
A	O
phenotype	O
and	O
genotype	O
correlation	O
was	O
demonstrated	O
in	O
1	O
pedigree	O
,	O
and	O
phenotypic	O
heterogeneity	O
(	O
Schnyder	O
'	O
s	O
crystalline	O
corneal	BP
dystrophy-21	IP
with	O
or	O
without	O
crystals	O
caused	O
by	O
a	O
same	O
mutation	O
of	O
Y174C-32	BG
in	O
the	O
UbiA	O
prenyltransferase	O
domain	O
-	O
containing	O
protein	O
1	O
gene-42	O
)	O
also	O
was	O
demonstrated	O
in	O
1	O
pedigree	O
.	O

PS1982	O
In	O
addition	O
,	O
two	O
cases	O
of	O
PLCE1-7	BG
mutations	O
associated	O
with	O
focal	BP
segmental	IP
glomerulosclerosis-13	IP
and	O
later	O
nephrotic	O
syndrome	O
onset	O
have	O
been	O
reported	O
.	O

PS1984	O
BRCA1-1	BG
and	O
BRCA2	BG
germline-4	IG
mutations	O
cause	O
a	O
substantially	O
increased	O
life	O
time	O
risk	O
of	O
both	O
breast	O
and	O
ovarian	O
cancer-18	BP
.	O

PS1985	O
Predictions	O
on	O
the	O
BRCA1-4	BG
/	O
BRCA2	BG
protein-7	IG
functions	O
lead	O
to	O
the	O
identification	O
of	O
11	O
novel	O
deleterious	O
cancer-17	BP
predisposing	O
mutations	O
.	O

PS1987	O
Predictions	O
on	O
the	O
BRCA1-4	BG
/	O
BRCA2	BG
protein-7	IG
functions	O
lead	O
to	O
the	O
identification	O
of	O
11	O
novel	O
deleterious	O
cancer-17	BP
predisposing	O
mutations	O
.	O

PS1989	O
Rett	O
syndrome	O
is	O
an	O
X	O
-	O
linked	O
autism	O
spectrum	BP
disorder-10	IP
caused	O
by	O
mutations	O
in	O
the	O
MeCP2	BG
gene-17	IG
in	O
the	O
great	O
majority	O
of	O
cases	O
.	O

PS1990	O
Idiopathic	O
infantile	BP
nystagmus-3	IP
can	O
be	O
hereditary	O
,	O
the	O
most	O
common	O
and	O
best	O
analyzed	O
form	O
being	O
a	O
mutation	O
of	O
the	O
FRMD7	BG
gene-21	IG
on	O
chromosome	O
Xq26	O
.	O

PS2000	O
T235	BG
alleles-2	IG
,	O
however	O
,	O
occurred	O
more	O
frequently	O
in	O
the	O
essential	O
hypertension-12	BP
group	O
and	O
less	O
frequently	O
in	O
the	O
group	O
of	O
myocardial	BP
infarction-22	IP
survivors	O
.	O

PS2014	O
Spinal	BP
muscular	IP
atrophy-3	IP
is	O
an	O
autosomal	O
recessive	O
disorder	O
associated	O
with	O
homozygous	O
deletion	O
of	O
the	O
survival	BG
motor	IG
neuron	IG
1	IG
gene-19	IG
.	O

PS2015	O
SMN2-1	BG
copynumber	O
was	O
highly	O
correlated	O
with	O
survival	O
duration	O
in	O
Spinal	O
muscular	BP
atrophy-12	IP
type	O
I	O
and	O
ambulation	O
conservation	O
or	O
loss	O
in	O
type	O
III	O
.	O

PS2026	O
Cystic	BP
fibrosis-2	IP
is	O
caused	O
by	O
mutations	O
in	O
cystic	BG
fibrosis	IG
transmembrane	IG
conductance	IG
regulator-12	IG
and	O
is	O
characterized	O
by	O
chronic	O
lung	O
infections	O
.	O

PS2046	O
In	O
LEOPARD	O
syndrome	O
,	O
mutations	O
affecting	O
exon	O
13	O
of	O
the	O
PTPN11	BG
gene-12	IG
have	O
been	O
correlated	O
with	O
a	O
rapidly	O
progressive	O
severe	O
biventricular	O
obstructive	O
hypertrophic	BP
cardiomyopathy-24	IP
.	O

PS2084	O
Defects	O
in	O
the	O
enzyme	O
porphobilinogen	BG
deaminase-6	IG
are	O
associated	O
with	O
acute	BP
intermittent	IP
porphyria-12	IP
.	O

PS2088	O
A	O
novel	O
missense	O
mutation	O
of	O
cardiac	BG
troponin	IG
I-8	IG
was	O
identified	O
in	O
a	O
patient	O
with	O
hypertrophic	BP
cardiomyopathy-16	IP
,	O
this	O
mutation	O
might	O
be	O
the	O
disease	O
-	O
causing	O
gene	O
mutation	O
in	O
this	O
Chinese	O
patient	O
.	O

PS2095	O
These	O
results	O
suggest	O
that	O
genomic	O
GATA4-6	BG
and	O
TFAP2B-8	BG
missense	O
mutations	O
may	O
be	O
associated	O
with	O
nonfamilial	O
congenital	BP
heart	IP
disease-18	IP
with	O
diverse	O
clinical	O
phenotypes	O
in	O
patients	O
with	O
congenital	BP
heart	IP
disease-28	IP
from	O
southern	O
China	O
.	O

PS2100	O
Although	O
genetically	O
heterogeneous	O
,	O
mutations	O
in	O
the	O
RYR1	BG
gene-9	IG
(	O
19q13	O
.	O
1	O
)	O
are	O
associated	O
with	O
the	O
majority	O
of	O
reported	O
Malignant	BP
hyperthermia-23	IP
cases	O
.	O

PS2112	O
The	O
association	O
between	O
GSTM1-4	BG
polymorphism	O
and	O
lung	O
cancer-8	BP
risk	O
is	O
not	O
so	O
strong	O
,	O
however	O
.	O

PS2126	O
Mutations	O
in	O
ROR2-3	BG
,	O
encoding	O
a	O
receptor	BG
tyrosine	IG
kinase-9	IG
,	O
can	O
cause	O
autosomal	O
recessive	O
Robinow	O
syndrome	O
,	O
a	O
severe	O
skeletal	BP
dysplasia-21	IP
with	O
limb	O
shortening	O
,	O
brachydactyly-26	BP
,	O
and	O
a	O
dysmorphic	O
facial	O
appearance	O
.	O

PS2142	O
Also	O
plasma	O
Uteroglobin	BG
-	IG
related	IG
protein	IG
1-7	IG
levels	O
were	O
shown	O
to	O
be	O
associated	O
both	O
with	O
this	O
polymorphism	O
and	O
the	O
severity	O
of	O
asthma-22	BP
.	O

PS2146	O
Homozygous	O
mutations	O
of	O
the	O
telomeric	O
SMN1	BG
gene-7	IG
lead	O
to	O
degeneration	O
of	O
motor	O
neurons	O
causing	O
spinal	BP
muscular	IP
atrophy-17	IP
.	O

PS2166	O
The	O
neurofibromatosis	BG
type	IG
2	IG
gene-5	IG
is	O
commonly	O
biallelically	O
inactivated	O
in	O
both	O
schwannomas	O
and	O
meningiomas-14	BP
.	O

PS2190	O
In	O
conclusion	O
,	O
the	O
serum	O
concentration	O
of	O
Matrix	BG
metalloproteinase	IG
-	IG
3-11	IG
is	O
influenced	O
by	O
Matrix	BG
metalloproteinase	IG
-	IG
3	IG
-	IG
1612	IG
5A	IG
/	IG
6A	IG
genotype-24	IG
and	O
associated	O
with	O
myocardial	BP
infarction-29	IP
.	O

PS2201	O
Among	O
the	O
candidate	O
genes	O
already	O
described	O
for	O
Wolf	O
-	O
Hirschhorn	O
syndrome	O
,	O
LETM1-13	BG
(	O
leucine	O
zipper	O
/	O
EF	O
-	O
hand	O
-	O
containing	O
transmembrane	O
)	O
is	O
likely	O
to	O
be	O
pathogenetically	O
involved	O
in	O
seizures-32	BP
.	O

PS2208	O
Familial	BP
hypercholesterolemia-2	IP
is	O
an	O
inherited	O
disease	O
characterized	O
by	O
the	O
deposition	O
of	O
LDL-12	BG
in	O
tissues	O
causing	O
premature	O
atherosclerosis	O
.	O

PS2218	O
In	O
contrast	O
,	O
mutant	BG
adenomatous	IG
polyposis	IG
coli	IG
gene	IG
products-9	IG
that	O
are	O
associated	O
with	O
attenuated	O
polyposis-15	BP
(	O
codon	O
386	O
or	O
1465	O
)	O
interfered	O
only	O
weakly	O
with	O
wild	O
-	O
type	O
adenomatous	O
polyposis	O
coli	O
activity	O
.	O

PS2220	O
Congenital	O
erythropoietic	BP
porphyria-3	IP
is	O
an	O
autosomal	O
recessive	O
cutaneous	O
porphyria	O
caused	O
by	O
decreased	O
activity	O
of	O
uroporphyrinogen	BG
III	IG
synthase-17	IG
.	O

PS2224	O
Multiple	O
endocrine	O
neoplasia-3	BP
type	O
1	O
syndrome	O
is	O
an	O
autosomal	O
dominant	O
disorder	O
caused	O
by	O
germline	O
mutations	O
in	O
the	O
MEN1	BG
gene-19	IG
and	O
characterized	O
by	O
multiple	O
endocrine	O
tumors	O
,	O
most	O
notably	O
in	O
the	O
parathyroid	O
glands	O
,	O
pituitary	O
,	O
and	O
pancreas	O
.	O

PS2226	O
Pancreatic	O
and	O
periampullary	O
cancers-4	BP
have	O
a	O
high	O
incidence	O
of	O
activating	O
KRAS-11	BG
mutations	O
.	O

PS2233	O
Results	O
of	O
immunohistochemistry	O
revealed	O
that	O
Monocyte	BG
chemotactic	IG
protein	IG
-	IG
1-10	IG
was	O
expressed	O
in	O
keratinocytes	O
,	O
infiltrating	O
inflammatory	O
cells	O
,	O
fibroblasts	O
,	O
and	O
endothelial	O
cells	O
in	O
scleroderma-26	BP
skin	O
,	O
whereas	O
normal	O
control	O
skin	O
showed	O
no	O
Monocyte	BG
chemotactic	IG
protein	IG
-	IG
1	IG
expression	IG
.	O

PS2242	O
Steroid	BG
21	IG
-	IG
hydroxylase-4	IG
deficiency	O
is	O
a	O
most	O
frequent	O
cause	O
of	O
congenital	BP
adrenal	IP
hyperplasia-14	IP
,	O
due	O
to	O
mutations	BG
in	IG
the	IG
CYP21A2	IG
gene-22	IG
.	O

PS2249	O
This	O
is	O
the	O
first	O
report	O
discussing	O
the	O
phenotypes	O
of	O
South	O
Korean	O
primary	O
congenital	O
glaucoma-14	BP
patients	O
associated	O
with	O
CYP1B1-18	BG
mutations	O
.	O

PS2251	O
Germline	O
missense	O
mutations	O
of	O
the	O
RET	BG
protooncogene-7	IG
cause	O
a	O
clinical	O
spectrum	O
called	O
multiple	O
endocrine	O
neoplasia-15	BP
type	O
2	O
.	O

PS2252	O
S891A-1	BG
mutation	O
caused	O
medullary	O
thyroid	BP
cancer-6	IP
in	O
69	O
.	O
4	O
%	O
,	O
pheochromocytoma	O
in	O
2	O
.	O
8	O
%	O
,	O
and	O
parathyroid	BP
hyperplasia-22	IP
in	O
8	O
.	O
3	O
%	O
of	O
the	O
36	O
patients	O
of	O
this	O
case	O
series	O
and	O
in	O
63	O
.	O
5	O
,	O
4	O
.	O
1	O
,	O
and	O
4	O
.	O
1	O
%	O
,	O
respectively	O
,	O
for	O
the	O
entire	O
groups	O
of	O
74	O
patients	O
.	O

PS2272	O
The	O
inactive	O
myostatin	BG
allele-4	IG
had	O
a	O
large	O
positive	O
effect	O
on	O
weaned	BP
heifer-12	IP
muscle	O
score	O
,	O
unfavorable	O
effects	O
on	O
calving	O
difficulty	O
and	O
skeleton	O
score	O
,	O
and	O
small	O
effects	O
on	O
birth	O
and	O
weaning	O
weight	O
.	O

PS2282	O
A	O
further	O
test	O
of	O
this	O
hypothesis	O
is	O
provided	O
by	O
a	O
unique	O
family	O
segregating	O
two	O
FGFR2-15	BG
mutations	O
in	O
cis	O
(	O
S252L	O
;	O
A315S	O
)	O
,	O
in	O
which	O
severe	O
syndactyly	O
occurs	O
in	O
the	O
absence	O
of	O
the	O
craniosynostosis-35	BP
that	O
typically	O
accompanies	O
FGFR2-39	BG
mutations	O
.	O

PS2284	O
Different	O
classes	O
of	O
HOXD13-4	BG
mutations	O
are	O
involved	O
in	O
the	O
pathogenesis	O
of	O
synpolydactyly-12	BP
,	O
but	O
an	O
unequivocal	O
genotype	O
-	O
phenotype	O
correlation	O
cannot	O
always	O
be	O
achieved	O
due	O
to	O
the	O
lack	O
of	O
structure	O
-	O
function	O
data	O
of	O
HOXD13-35	BG
.	O

PS2292	O
By	O
obtaining	O
these	O
genetic	O
mutation	O
data	O
,	O
we	O
are	O
contributing	O
to	O
an	O
overview	O
of	O
all	O
ABCC6	BG
mutations-17	IG
leading	O
to	O
Pseudoxanthoma-20	BP
elasticum	O
and	O
the	O
pathogenetics	O
of	O
this	O
disease	O
.	O

PS2296	O
No	O
ESR1	BG
SNP-3	IG
was	O
associated	O
with	O
obesity-7	BP
.	O

PS2298	O
A	O
minor	O
importance	O
of	O
ESR2-5	BG
on	O
severe	O
obesity-8	BP
cannot	O
be	O
excluded	O
.	O

PS2307	O
Netherton	O
syndrome	O
is	O
a	O
congenital	BP
ichthyosiform	IP
dermatosis-7	IP
caused	O
by	O
serine	BG
protease	IG
inhibitor	IG
Kazal	IG
-	IG
type	IG
5-16	IG
mutations	O
.	O

PS2333	O
HLA	BG
-	IG
A30-3	IG
and	O
HLA	BG
-	IG
DR7-7	IG
seem	O
to	O
be	O
predisposing	O
genes	O
for	O
Posttransplantation	O
diabetes	BP
mellitus-16	IP
in	O
patients	O
in	O
the	O
south	O
of	O
China	O
;	O

PS2350	O
There	O
was	O
no	O
association	O
between	O
the	O
presence	O
of	O
germline	O
or	O
tissue	O
R337H	BG
p53-13	IG
mutation	O
and	O
malignancy-16	BP
at	O
diagnosis	O
.	O

PS2353	O
Patient	BG
human	IG
leucocyte	IG
antigen	IG
-	IG
DRB1-6	IG
serotypes	O
were	O
assessed	O
and	O
the	O
genotypes	O
encoding	O
the	O
shared	O
epitope	O
motif	O
or	O
the	O
putatively	O
protective	O
D70	BG
motif-23	IG
identified	O
in	O
a	O
large	O
rheumatoid	BP
arthritis	IP
cohort-30	IP
.	O

PS2372	O
This	O
family	O
adds	O
further	O
to	O
the	O
genotype	O
-	O
phenotype	O
correlation	O
of	O
the	O
dysfibrinogenaemias	O
and	O
provides	O
strong	O
evidence	O
for	O
a	O
genuine	O
association	O
of	O
fibrinogen	BG
BbetaArg14Cys	IG
with	O
thrombosis-26	BP
.	O

PS2403	O
The	O
present	O
study	O
was	O
undertaken	O
to	O
investigate	O
whether	O
rare	O
variants	O
of	O
TNFAIP3-12	BG
and	O
TREX1-14	BG
are	O
also	O
associated	O
with	O
systemic	O
sclerosis-20	BP
.	O

PS2404	O
No	O
association	O
between	O
TREX1-4	BG
variants	O
and	O
systemic	O
sclerosis-8	BP
was	O
observed	O
.	O

PS2417	O
Myophosphorylase-1	BG
deficiency	O
is	O
characterized	O
by	O
exercise	O
intolerance	O
,	O
muscle	O
cramps	O
,	O
and	O
recurrent	BP
myoglobinuria-14	IP
.	O

PS2421	O
all	O
seven	O
cases	O
of	O
gastric	BP
cancer-6	IP
occurred	O
in	O
families	O
with	O
SMAD4-11	BG
mutations	O
.	O

PS2433	O
Three	O
cytochrome	BG
P4501B1-3	IG
mutations	O
were	O
identified	O
in	O
5	O
primary	O
congenital	O
glaucoma-11	BP
patients	O
(	O
45	O
.	O
4	O
%	O
)	O
of	O
which	O
2	O
were	O
novel	O
(	O
homozygous	BG
E173K-26	IG
and	O
heterozygous	BG
N498D	IG
)	O
and	O
the	O
third	O
(	O
G61E	BG
)	O
had	O
previously	O
been	O
reported	O
.	O

PS2466	O
Germline	O
mutations	O
of	O
the	O
tumor	O
suppressor	O
gene	O
multiple	O
endocrine	BG
neoplasia	IG
type	IG
1-12	IG
are	O
found	O
not	O
only	O
in	O
typical	BP
multiple	IP
endocrine	IP
neoplasia	IP
type	IP
1	IP
but	O
also	O
in	O
its	O
incomplete	O
forms	O
such	O
as	O
familial	O
isolated	O
hyperparathyroidism-34	BP
and	O
apparently	O
sporadic	O
parathyroid	O
tumor	O
.	O

PS2470	O
RET	BG
mutations-2	IG
predispose	O
an	O
individual	O
to	O
the	O
development	O
of	O
medullary	O
thyroid	BP
carcinomas-12	IP
and	O
can	O
also	O
influence	O
the	O
individual	O
response	O
to	O
RET	BG
protein	IG
receptor-23	IG
-	O
targeted	O
therapies	O
.	O

PS2488	O
Phenotype	O
/	O
genotype	O
correlation	O
indicates	O
that	O
G309R-7	BG
is	O
a	O
deleterious	O
mutation	O
that	O
can	O
lead	O
to	O
seizures-16	BP
and	O
a	O
lethal	O
outcome	O
,	O
as	O
was	O
demonstrated	O
in	O
our	O
patient	O
.	O

PS2499	O
The	O
peripheral	O
myelin	BG
protein	IG
22	IG
mutation	IG
W28R-7	IG
was	O
associated	O
with	O
Charcot	O
-	O
Marie	O
-	O
Tooth	O
disease1	O
and	O
profound	O
deafness-19	BP
.	O

PS2506	O
Preliminary	O
genotype	O
/	O
phenotype	O
correlation	O
seems	O
to	O
indicate	O
that	O
other	O
genes	O
involved	O
in	O
the	O
regulation	O
of	O
human	O
pigmentation-18	BP
may	O
mask	O
the	O
recessive	O
action	O
of	O
high	BG
-	IG
penetrance	IG
melanocortin	IG
-	IG
1	IG
receptor	IG
gene	IG
alleles-33	IG
,	O
thus	O
determining	O
the	O
low	O
frequency	O
of	O
at	O
-	O
risk	O
phototypes	O
and	O
of	O
incidence	O
and	O
/	O
or	O
penetrance	O
of	O
melanoma-53	BP
in	O
Liguria	O
.	O

PS2511	O
Among	O
subjects	O
with	O
a	O
JAG1	BG
mutation-6	IG
,	O
there	O
was	O
no	O
correlation	O
between	O
the	O
type	O
or	O
location	O
of	O
mutation	O
and	O
the	O
frequency	O
or	O
type	O
of	O
cardiovascular	BP
anomaly-26	IP
.	O

PS2525	O
Mutations	BG
in	IG
the	IG
XNP-4	BG
/	IG
ATR	IG
-	IG
X	IG
gene-9	IG
,	O
located	O
in	O
Xq13	O
.	O
3	O
,	O
are	O
associated	O
with	O
several	O
X	O
linked	O
mental	BP
retardation-24	IP
syndromes	O
,	O
the	O
best	O
known	O
being	O
alpha	BP
thalassaemia	IP
with	IP
mental	IP
retardation-35	IP
(	O
ATRX-39	BP
)	O
.	O

PS2548	O
Our	O
findings	O
indicate	O
that	O
(	O
i	O
)	O
both	O
variants	O
of	O
hepatocellular	BP
carcinoma-12	IP
arising	O
in	O
AAT-15	BG
deficiency	O
(	O
Z	O
and	O
Mmalton	O
)	O
do	O
not	O
accumulate	O
the	O
mutant	O
protein	O
and	O
(	O
ii	O
)	O
the	O
different	O
phenotypic	O
appearance	O
of	O
hepatocytes	O
is	O
not	O
the	O
result	O
of	O
a	O
retromutation	O
during	O
neoplastic	O
transformation	O
,	O
but	O
other	O
mechanisms	O
should	O
be	O
investigated	O
.	O

PS2552	O
Specific	O
cystic	BG
fibrosis	IG
transmembrane	IG
conductance	IG
regulator	IG
genotypes-7	IG
are	O
significantly	O
associated	O
with	O
pancreatitis-12	BP
.	O

PS2558	O
Furthermore	O
,	O
13	O
out	O
of	O
18	O
genes	O
selected	O
from	O
the	O
above	O
lists	O
were	O
successfully	O
validated	O
by	O
QRT	O
-	O
PCR	O
(	O
Mann	O
-	O
Whitney	O
U	O
-	O
test	O
)	O
,	O
and	O
only	O
ATP	O
-	O
binding	O
cassetteB1	BG
gene-35	IG
exhibited	O
significantly	O
positive	O
correlation	O
with	O
MMSE	O
scores	O
among	O
normal	O
controls	O
,	O
mild	O
cognitive	BP
impairment-49	IP
,	O
and	O
Alzheimer	O
'	O
s	O
disease	O
subjects	O
(	O
r	O
=	O
0	O
.	O
3858	O
,	O
p	O
=	O
0	O
.	O
0011	O
)	O
.	O

PS2566	O
Familial	BP
glucocorticoid	IP
deficiency-3	IP
(	O
FGD	O
)	O
is	O
a	O
rare	O
autosomal	O
recessive	O
disorder	O
,	O
characterized	O
by	O
resistance	O
to	O
ACTH-18	BG
leading	O
to	O
glucocorticoid	BP
deficiency-22	IP
,	O
but	O
not	O
mineralocorticoid	BP
deficiency-27	IP
.	O

PS2570	O
This	O
study	O
demonstrates	O
a	O
statistical	O
correlation	O
between	O
intratumoural	O
differences	O
in	O
neoplastic	O
degree	O
of	O
dedifferentiation	O
and	O
genetic	O
instability	O
in	O
terms	O
of	O
Loss	O
of	O
heterozygosity	O
and	O
point	O
mutations	O
of	O
the	O
k	BG
-	IG
ras	IG
gene-32	IG
in	O
colorectal	BP
carcinoma-35	IP
.	O

PS2597	O
Genetic	O
linkage	O
analysis	O
using	O
polymorphisms	O
in	O
the	O
alpha	BG
-	IG
and	IG
beta	IG
-	IG
myosin	IG
heavy	IG
chain	IG
genes-17	IG
revealed	O
that	O
familial	O
hypertrophic	BP
cardiomyopathy-22	IP
in	O
this	O
family	O
is	O
significantly	O
linked	O
to	O
the	O
beta	BG
-	IG
myosin	IG
heavy	IG
chain	IG
gene-36	IG
without	O
recombinations	O
.	O

PS2599	O
Amino	O
acid	O
substitutions	O
Asn540Lys	O
,	O
Asn540Thr	O
and	O
Ile538Val	O
in	O
the	O
fibroblast	BG
growth	IG
factor	IG
receptor	IG
3-15	IG
are	O
considered	O
to	O
cause	O
hypochondroplasia-20	BP
.	O

PS2604	O
ENPP1-1	BG
coding	O
region	O
mutations	O
are	O
associated	O
with	O
generalized	BP
arterial	IP
calcification-10	IP
of	O
infancy	O
in	O
approximately	O
75	O
%	O
of	O
subjects	O
.	O

PS2607	O
Evidence	O
from	O
this	O
study	O
is	O
not	O
conclusive	O
,	O
but	O
our	O
data	O
suggest	O
that	O
the	O
CYP1A1-15	BG
influences	O
disease	O
expression	O
in	O
individuals	O
with	O
Hereditary	O
nonpolyposis	O
colorectal	BP
cancer-25	IP
.	O

PS2619	O
In	O
particular	O
,	O
polymorphisms	O
in	O
the	O
ACE	BG
gene-8	IG
have	O
been	O
associated	O
with	O
diabetic	O
nephropathy-14	BP
and	O
,	O
in	O
some	O
studies	O
,	O
macrovascular	O
complications	O
.	O

PS2626	O
This	O
is	O
the	O
first	O
mutation	O
in	O
the	O
RyR1	BG
C	IG
-	IG
terminal	IG
region-12	IG
associated	O
solely	O
with	O
Malignant	BP
hyperthermiaS-17	IP
.	O

PS2644	O
The	O
albumin-2	BG
excretion	O
rate	O
was	O
independently	O
correlated	O
with	O
Lp	BG
(	IG
a	IG
)-12	IG
concentrations	O
in	O
a	O
multiple	O
regression	O
analysis	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
and	O
Lp	BG
(	IG
a	IG
)-31	IG
was	O
independently	O
associated	O
with	O
the	O
presence	O
of	O
diabetic	O
nephropathy-40	BP
in	O
the	O
logistic	O
regression	O
analysis	O
.	O

PS2645	O
The	O
overall	O
frequency	O
distribution	O
of	O
Lp	BG
(	IG
a	IG
)-9	IG
phenotypes	O
differed	O
significantly	O
between	O
patients	O
with	O
or	O
without	O
microalbuminuria-18	BP
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

PS2649	O
Overexpression	O
of	O
OTX2-3	BG
was	O
found	O
in	O
medulloblastoma-7	BP
,	O
a	O
malignant	O
brain	O
tumor	O
that	O
occurs	O
mainly	O
in	O
childhood	O
.	O

PS2653	O
Two	O
G	O
-	O
to	O
-	O
A	O
mutations	O
at	O
positions	O
1691	O
of	O
the	O
factor	O
V	O
gene	O
and	O
20210	O
of	O
the	O
prothrombin	BG
(	IG
FII	IG
)	IG
gene-24	IG
have	O
been	O
associated	O
with	O
an	O
increased	BP
risk	IP
of	IP
venous	IP
thromboembolism-34	IP
.	O

PS2662	O
In	O
addition	O
,	O
several	O
WFS1	BG
sequence	IG
variants-7	IG
have	O
been	O
shown	O
to	O
be	O
significantly	O
associated	O
with	O
diabetes	BP
mellitus-17	IP
and	O
this	O
gene	O
has	O
also	O
been	O
implicated	O
in	O
psychiatric	BP
diseases-27	IP
.	O

PS2665	O
The	O
present	O
study	O
found	O
the	O
correlation	O
of	O
apolipoprotein	BG
(	IG
a	IG
)-13	IG
[	O
apo	BG
(	IG
a	IG
)-15	IG
]	O
with	O
cerebral	BP
infarction-22	IP
at	O
the	O
levels	O
of	O
molecule	O
and	O
protein	O
.	O

PS2666	O
Our	O
study	O
found	O
that	O
the	O
low	O
molecular	O
weight	O
phenotype	O
of	O
apo-11	BG
(	O
a	O
)	O
was	O
closely	O
associated	O
with	O
cerebral	BP
infarction-20	IP
,	O
suggested	O
that	O
the	O
variation	O
of	O
serum	BG
Lp-28	IG
(	O
a	O
)	O
level	O
be	O
determined	O
by	O
not	O
only	O
the	O
size	O
of	O
apo	BG
(	IG
a	IG
)	IG
gene-45	IG
but	O
also	O
its	O
sequence	O
,	O
which	O
indicated	O
that	O
both	O
the	O
size	O
and	O
sequence	O
of	O
apo-60	BG
(	O
a	O
)	O
are	O
associated	O
with	O
the	O
susceptibility	O
to	O
cerebral	BP
infarction-71	IP
.	O

PS2667	O
These	O
data	O
may	O
provide	O
insight	O
into	O
the	O
mechanisms	O
by	O
which	O
major	BG
histocompatibility	IG
complex	IG
antigens-14	IG
increase	O
the	O
probability	O
of	O
developing	O
autoimmune	BP
disease-21	IP
and	O
may	O
help	O
explain	O
the	O
difficulty	O
of	O
defining	O
major	BG
histocompatibility	IG
complex-32	IG
relationships	O
in	O
human	O
systemic	BP
lupus	IP
erythematosus-38	IP
.	O

PS2672	O
adrenal	BP
hypoplasia	IP
congenita-3	IP
can	O
be	O
associated	O
with	O
glycerol	BG
kinase	IG
deficiency-10	IP
,	O
Duchenne	O
muscular	BP
dystrophy-14	IP
and	O
mental	BP
retardation-17	IP
,	O
as	O
part	O
of	O
a	O
contiguous	O
gene	O
deletion	O
syndrome	O
.	O

PS2683	O
The	O
discovery	O
that	O
mutations	O
in	O
the	O
RET	BG
proto	IG
-	IG
oncogene-10	IG
are	O
associated	O
with	O
multiple	O
endocrine	O
neoplasia-16	BP
-	O
II	O
syndromes	O
was	O
highly	O
significant	O
in	O
that	O
it	O
demonstrated	O
a	O
clear	O
correlation	O
between	O
genotype	O
and	O
phenotype	O
;	O

PS2684	O
Mutations	O
in	O
the	O
RUNX2	BG
gene-5	IG
have	O
been	O
shown	O
to	O
cause	O
Cleidocranial	BP
dysplasia-12	IP
.	O

PS2685	O
Type	O
I	O
hyperprolinemia-3	BP
is	O
an	O
autosomal	O
recessive	O
disorder	O
caused	O
by	O
proline	BG
oxidase-12	IG
deficiency	O
.	O

PS2690	O
Mucopolysaccharidosis-1	BP
type	O
IIIA	O
,	O
also	O
known	O
as	O
Sanfilippo	O
A	O
disease	O
,	O
results	O
from	O
mutations	O
in	O
the	O
sulfamidase	BG
gene-18	IG
.	O

PS2701	O
The	O
chymase	BG
-	IG
1	IG
-	IG
1903	IG
GG	IG
genotype-8	IG
was	O
associated	O
with	O
a	O
nonischemic	O
heart	BP
failure-15	IP
etiology	O
(	O
chi	O
=	O
6	O
.	O
67	O
,	O
P	O
=	O
0	O
.	O
009	O
)	O
.	O

PS2703	O
Conversely	O
,	O
the	O
angiotensin	BG
-	IG
converting	IG
enzyme	IG
D	IG
allele-9	IG
had	O
no	O
detectable	O
impact	O
on	O
systolic	O
heart	BP
failure-17	IP
phenotype	O
.	O

PS2733	O
Mitochondrial	O
neurogastrointestinal	O
encephalomyopathy-3	BP
is	O
an	O
autosomal	O
recessive	O
disease	O
caused	O
by	O
mutations	O
in	O
the	O
gene	O
encoding	O
thymidine	BG
phosphorylase-17	IG
.	O

PS2736	O
Cystic	BP
fibrosis-2	IP
is	O
caused	O
by	O
mutations	O
of	O
the	O
gene	O
encoding	O
for	O
the	O
Cystic	BG
fibrosis	IG
transmembrane	IG
conductance	IG
regulator	IG
protein-18	IG
.	O

PS2742	O
PTEN-1	BG
is	O
one	O
of	O
the	O
most	O
frequently	O
mutated	O
tumor	O
suppressor	O
genes	O
in	O
human	O
cancers-14	BP
.	O

PS2744	O
While	O
Arginine	O
719Tryptophan	O
mutation	O
in	O
the	O
beta	BG
-	IG
myosin	IG
heavy	IG
chain	IG
gene-12	IG
is	O
associated	O
with	O
a	O
high	O
incidence	O
of	O
sudden	BP
cardiac	IP
death-22	IP
,	O
the	O
Valine	O
606Methionine	O
mutation	O
in	O
the	O
same	O
gene	O
is	O
associated	O
with	O
a	O
near	O
normal	O
life	O
expectancy	O
.	O

PS2757	O
Furthermore	O
,	O
in	O
a	O
case	O
-	O
control	O
study	O
examining	O
single	O
nucleotide	O
polymorphisms	O
in	O
the	O
Baculoviral	O
IAP	O
repeat	O
containing	O
5	O
regulatory	O
regions	O
,	O
the	O
minor	O
alleles	O
of	O
rs8073903-27	BG
and	O
rs8073069-29	BG
were	O
found	O
to	O
be	O
significantly	O
associated	O
with	O
asthma-37	BP
and	O
especially	O
non	O
-	O
allergic	O
asthma	O
phenotypes	O
,	O
which	O
associations	O
were	O
more	O
prominent	O
among	O
women	O
.	O

PS2758	O
In	O
the	O
female	O
cohort	O
,	O
rs1508147-6	BG
was	O
also	O
significantly	O
associated	O
with	O
increased	O
risk	O
of	O
non	O
-	O
allergic	O
asthma-18	BP
.	O

PS2759	O
Immunodeficiency	O
,	O
centromeric	O
instability	O
and	O
facial	BP
dysmorphism-7	IP
(	O
ICF	O
syndrome	O
)	O
is	O
a	O
rare	O
autosomal	O
recessive	O
disease	O
characterised	O
by	O
facial	O
dysmorphism	O
,	O
immunoglobulin	BG
deficiency-24	IP
and	O
branching	O
of	O
chromosomes	O
1	O
,	O
9	O
and	O
16	O
after	O
PHA	O
stimulation	O
of	O
lymphocytes	O
.	O

PS2790	O
Chloroquine	BP
resistance-2	IP
phenotype	O
in	O
Plasmodium	O
falciparum	O
is	O
associated	O
with	O
mutations	O
in	O
pfcrt	O
and	O
pfmdr	BG
-	IG
1	IG
genes-17	IG
.	O

PS2796	O
Paramyotonia	O
congenita	O
of	O
von	BG
Eulenburg-5	IG
is	O
an	O
autosomal	O
dominant	O
muscular	O
disease	O
characterized	O
by	O
exercise	O
-	O
and	O
cold	O
-	O
induced	O
myotonia-20	BP
and	O
weakness	O
.	O

PS2805	O
Both	O
association	O
and	O
functional	O
studies	O
suggested	O
that	O
apelin	BG
gene-9	IG
polymorphisms	O
were	O
associated	O
with	O
risks	O
of	O
obesity-16	BP
phenotypes	O
.	O

PS2807	O
Serum	O
levels	O
of	O
anti	BG
-	IG
gp70	IG
Abs-7	IG
were	O
closely	O
correlated	O
with	O
the	O
presence	O
of	O
renal	BP
disease-16	IP
,	O
more	O
so	O
than	O
anti	BG
-	IG
dsDNA	IG
Abs-24	IG
.	O

PS2820	O
Excessive	O
activation	O
of	O
the	O
transforming	BG
growth	IG
factor	IG
beta-8	IG
signaling	O
pathway	O
and	O
disorganized	O
cellular	O
skeleton	O
caused	O
by	O
genetic	O
mutations	O
are	O
known	O
to	O
be	O
responsible	O
for	O
the	O
inherited	O
thoracic	O
aortic	BP
aneurysms-29	IP
and	O
dissections	O
,	O
a	O
life	O
-	O
threatening	O
vascular	O
disease	O
.	O

PS2822	O
Thus	O
,	O
we	O
conclude	O
that	O
exon	O
47	O
skipping	O
of	O
fibrillin	BG
-	IG
1-12	IG
leads	O
preferentially	O
to	O
cardiovascular	O
defects	O
and	O
human	O
ancestries	O
influence	O
genotype	O
-	O
phenotype	O
correlation	O
in	O
thoracic	O
aortic	BP
aneurysms-29	IP
and	O
dissections	O
.	O

PS2836	O
The	O
NS3P-2	BG
expression	O
was	O
lower	O
in	O
hepatocellular	BP
carcinoma-8	IP
(	O
65	O
.	O
6	O
%	O
)	O
than	O
in	O
MNT	O
(	O
94	O
.	O
4	O
%	O
)	O
patients	O
.	O

PS2840	O
The	O
carcinogenic	O
effect	O
of	O
NS3P-5	BG
is	O
probably	O
exerted	O
at	O
an	O
early	O
stage	O
of	O
hepatocellular	BP
carcinoma-15	IP
possibly	O
through	O
a	O
pathway	O
involving	O
c	BG
-	IG
erbB2-23	IG
and	O
p21-25	BG
(	O
waf	O
)	O
alterations	O
.	O

PS2856	O
This	O
region	O
was	O
syntenic	O
with	O
the	O
jvs	BG
locus-8	IG
,	O
which	O
is	O
responsible	O
for	O
murine	O
systemic	BP
carnitine	IP
deficiency-17	IP
.	O

PS2861	O
Genotype	O
-	O
phenotype	O
correlation	O
in	O
our	O
cases	O
together	O
with	O
cases	O
reported	O
in	O
the	O
literature	O
suggested	O
that	O
copy	O
-	O
number	O
gains	O
between	O
two	O
low	O
copy	O
repeats	O
(	O
LCRK1-27	BG
and	O
LCRL1-29	BG
)	O
are	O
associated	O
with	O
the	O
incidence	O
of	O
hypoplasia	BP
of	IP
the	IP
corpus	IP
callosum-41	IP
.	O

PS2864	O
Logistic	O
regression	O
analysis	O
showed	O
a	O
significant	O
correlation	O
between	O
rs35320474	BG
-	IG
C	IG
/	IG
T-13	IG
and	O
T	BG
/	IG
T	IG
genotypes-18	IG
and	O
apnoea	BP
and	O
bronchopulmonary	BP
dysplasia-23	IP
development	O
.	O

PS2869	O
We	O
postulate	O
that	O
there	O
is	O
a	O
transcriptional	O
regulation	O
of	O
HLA	BG
class	IG
I	IG
gene-13	IG
expression	O
in	O
melanoma-16	BP
cells	O
.	O

PS2875	O
The	O
strength	O
of	O
association	O
between	O
cytochrome	BG
P450	IG
1A1	IG
T3801C	IG
polymorphism	IG
and	O
breast	BP
cancer-13	IP
risk	O
was	O
assessed	O
by	O
calculating	O
crude	O
ORs	O
with	O
95	O
%	O
CIs	O
.	O

PS2876	O
Overall	O
,	O
no	O
significant	O
associations	O
between	O
cytochrome	BG
P450	IG
1A1	IG
T3801C	IG
polymorphism-11	IG
and	O
breast	BP
cancer-14	IP
susceptibility	O
were	O
found	O
for	O
TT	O
versus	O
CC	O
(	O
OR	O
=	O
0	O
.	O
93	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
72	O
-	O
1	O
.	O
19	O
)	O
,	O
TC	O
versus	O
CC	O
(	O
OR	O
=	O
0	O
.	O
95	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
79	O
-	O
1	O
.	O
14	O
)	O
,	O
TT	O
+	O
TC	O
versus	O
CC	O
(	O
OR	O
=	O
0	O
.	O
93	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
75	O
-	O
1	O
.	O
15	O
)	O
,	O
and	O
TT	O
versus	O
TC	O
+	O
CC	O
(	O
OR	O
=	O
0	O
.	O
99	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
87	O
-	O
1	O
.	O
13	O
)	O
.	O

PS2880	O
The	O
presence	O
of	O
skeletal	BP
abnormalities	IP
correlates	O
with	O
RECQL4	BG
mutation-9	IG
status	O
,	O
which	O
has	O
been	O
found	O
to	O
correlate	O
with	O
risk	O
of	O
osteosarcoma-21	BP
.	O

PS2882	O
Primary	BP
carnitine	IP
deficiency-3	IP
is	O
caused	O
by	O
defective	O
OCTN2	BG
carnitine	IG
transporters-10	IG
encoded	O
by	O
the	O
SLC22A5	BG
gene-15	IG
.	O

PS2889	O
Autosomal	O
dominant	O
oculopharyngeal	O
muscular	BP
dystrophy-5	IP
,	O
with	O
late	O
onset	O
due	O
to	O
ptosis-12	BP
and	O
/	O
or	O
dysphagia	O
,	O
is	O
caused	O
by	O
short	O
(	O
GCG	O
)	O
8	O
-	O
13	O
triplet	O
-	O
repeat	O
expansions	O
in	O
the	O
polyadenylation	BG
binding	IG
protein	IG
2-37	IG
gene	O
,	O
which	O
is	O
localized	O
in	O
chromosome	O
14q11	O
.	O

PS2900	O
The	O
p53	BG
tumor	IG
suppressor	IG
gene-5	IG
is	O
altered	O
in	O
human	O
cancer-10	BP
.	O

PS2917	O
G20210A	BG
prothrombin	IG
mutation-3	IG
has	O
been	O
associated	O
with	O
high	O
prothrombin-9	BG
levels	O
and	O
an	O
increased	BP
risk	IP
of	IP
venous	IP
thrombosis-17	IP
.	O

PS2921	O
G20210A	BG
prothrombin	IG
mutation-3	IG
has	O
been	O
associated	O
with	O
high	O
prothrombin-9	BG
levels	O
and	O
an	O
increased	BP
risk	IP
of	IP
venous	IP
thrombosis-17	IP
.	O

PS2937	O
In	O
particular	O
,	O
the	O
correlation	O
between	O
congenital	BP
hypertrophy	IP
of	IP
the	IP
retinal	IP
pigment	IP
epithelium-13	IP
and	O
APC	BG
genotype-16	IG
indicates	O
that	O
affected	O
families	O
may	O
be	O
divided	O
into	O
distinct	O
groups	O
.	O

PS2941	O
Case-1	BG
reports	O
have	O
associated	O
alpha1	BG
-	IG
antitrypsin-7	IG
deficiency	O
and	O
fibromuscular	BP
dysplasia-11	IP
.	O

PS2949	O
This	O
study	O
is	O
the	O
first	O
large	O
systematic	O
analysis	O
indicating	O
that	O
the	O
GJB2	BG
genotype-13	IG
has	O
a	O
major	O
impact	O
on	O
the	O
degree	O
of	O
hearing	BP
impairment-23	IP
,	O
and	O
identifying	O
mild	O
genotypes	O
.	O

PS2951	O
Oligodendrogliomas	O
typically	O
show	O
loss	O
of	O
heterozygosity	O
on	O
chromosomes	O
1p	O
and	O
19q	O
,	O
which	O
correlates	O
with	O
their	O
response	O
to	O
chemotherapy	O
,	O
whereas	O
low	O
-	O
grade	O
astrocytomas-25	BP
are	O
characterized	O
by	O
frequent	O
TP53	BG
mutations-31	IG
and	O
lack	O
of	O
sensitivity	O
to	O
alkylating	O
therapeutic	O
agents	O
.	O

PS2971	O
The	O
genotype	O
distribution	O
of	O
the	O
CTLA	BG
-	IG
4	IG
promoter-10	IG
differed	O
between	O
systemic	BP
lupus	IP
erythematosus-19	IP
patients	O
and	O
control	O
subjects	O
.	O

PS2983	O
Testing	O
results	O
from	O
a	O
cohort	O
of	O
550	O
cases	O
,	O
including	O
patients	O
with	O
different	O
forms	O
of	O
dystonia-16	BP
and	O
unclassified	O
movement	O
disorders	O
,	O
revealed	O
that	O
72	O
.	O
2	O
%	O
of	O
the	O
patients	O
with	O
typical	BP
early	IP
-	IP
onset	IP
generalized	IP
primary	IP
torsion	IP
dystonia	IP
carried	O
the	O
GAG	O
deletion	O
in	O
the	O
DYT1	BG
gene-47	IG
.	O

PS3000	O
Besides	O
known	O
risk	O
factors	O
(	O
female	O
gender	O
,	O
nonsmoker	O
,	O
history	O
,	O
and	O
opioids	O
)	O
,	O
a	O
genetic	O
influence	O
of	O
the	O
serotonin	BG
receptor-23	IG
system	O
on	O
the	O
development	O
of	O
nausea-29	BP
and	O
vomiting-31	BP
has	O
repeatedly	O
been	O
proposed	O
.	O

PS3002	O
Genetic	O
variations	O
in	O
the	O
HTR3A-5	BG
and	O
HTR3B	BG
gene-8	IG
seem	O
to	O
be	O
associated	O
with	O
the	O
individual	O
risk	O
of	O
developing	O
postoperative	O
vomiting-20	BP
.	O

PS3004	O
Proximal	O
spinal	BP
muscular	IP
atrophy-4	IP
results	O
from	O
loss	O
of	O
the	BG
survival	IG
motor	IG
neuron	IG
1	IG
gene	IG
,	O
with	O
retention	O
of	O
its	O
nearly	O
identical	O
homolog	O
,	O
SMN2-24	BG
.	O

PS3016	O
Mutations	O
in	O
the	O
receptor	BG
expression	IG
enhancing	IG
protein	IG
1-8	IG
have	O
recently	O
been	O
reported	O
to	O
cause	O
autosomal	O
dominant	O
hereditary	O
spastic	BP
paraplegia-19	IP
type	O
SPG31	O
.	O

PS3020	O
Mutations	O
in	O
the	O
gene	O
encoding	O
phenylalanine	BG
hydroxylase-7	IG
cause	O
persistent	O
hyperphenylalaninaemia-10	BP
.	O

PS3053	O
TDP	BG
-	IG
43-3	IG
has	O
been	O
identified	O
as	O
a	O
major	O
component	O
of	O
protein	O
inclusions	O
in	O
the	O
brain	O
of	O
patients	O
with	O
amyotrophic	BP
lateral	IP
sclerosis-22	IP
;	O

PS3055	O
Results	O
showed	O
that	O
TDP	BG
-	IG
43	IG
plasma-7	IG
levels	O
were	O
significantly	O
increased	O
in	O
patients	O
with	O
amyotrophic	BP
lateral	IP
sclerosis-17	IP
(	O
p	O
=	O
0	O
.	O
023	O
)	O
and	O
we	O
found	O
a	O
positive	O
correlation	O
with	O
age	O
in	O
patients	O
and	O
controls	O
.	O

PS3060	O
Cystic	BP
fibrosis-2	IP
is	O
caused	O
by	O
cystic	BG
fibrosis	IG
transmembrane	IG
conductance	IG
regulator-10	IG
gene	O
mutations	O
.	O

PS3068	O
Thrombocytopenia-1	BP
in	O
22q11	O
.	O
2	O
deletion	O
syndrome	O
patients	O
is	O
associated	O
with	O
decreased	O
expression	O
of	O
glycoprotein	BG
Ib	IG
-	IG
beta-18	IG
because	O
of	O
the	O
hemizygosity	O
.	O

PS3079	O
This	O
suggests	O
that	O
mutations	O
of	O
MYO15A-6	BG
are	O
responsible	O
for	O
at	O
least	O
5	O
%	O
of	O
recessively	O
inherited	O
,	O
profound	O
hearing	BP
loss-20	IP
in	O
Pakistan	O
.	O

PS3080	O
However	O
,	O
without	O
the	O
benefit	O
of	O
a	O
pre	O
-	O
screen	O
for	O
linkage	O
to	O
DFNB3-14	BG
,	O
we	O
determined	O
mutations	O
of	O
MYO15A-29	BG
contributes	O
to	O
hereditary	O
hearing	BP
loss-34	IP
among	O
isolated	O
cases	O
and	O
small	O
families	O
in	O
other	O
populations	O
.	O

PS3083	O
p63	BG
mutations	IG
have	O
been	O
associated	O
with	O
several	O
human	O
hereditary	O
disorders	O
characterized	O
by	O
ectodermal	BP
dysplasia-14	IP
such	O
as	O
EEC	O
(	O
ectrodactyly	O
,	O
ectodermal	BP
dysplasia-22	IP
,	O
clefting	O
)	O
syndrome	O
,	O
ADULT	O
(	O
acro	O
,	O
dermato	O
,	O
ungual	O
,	O
lacrimal	O
,	O
tooth	O
)	O
syndrome	O
and	O
AEC	O
(	O
ankyloblepharon	O
,	O
ectodermal	BP
dysplasia-47	IP
,	O
clefting	O
)	O
syndrome	O
(	O
also	O
called	O
Hay	O
-	O
Wells	O
syndrome	O
)	O
.	O

PS3086	O
The	O
aim	O
of	O
our	O
study	O
was	O
to	O
contribute	O
to	O
understanding	O
of	O
the	O
role	O
of	O
MYBPC3-15	BG
mutations	O
in	O
hypertrophic	BP
cardiomyopathy-19	IP
.	O

PS3088	O
Many	O
different	O
mutations	O
in	O
COL4A3-5	BG
and	O
COL4A4-7	BG
that	O
cause	O
Thin	O
basement	O
membrane	O
nephropathy-13	BP
have	O
already	O
been	O
identified	O
,	O
but	O
most	O
genetic	O
variability	O
in	O
these	O
genes	O
has	O
been	O
found	O
to	O
cause	O
autosomal	O
Alport	O
syndrome	O
.	O

PS3099	O
No	O
other	O
correlation	O
was	O
observed	O
between	O
Angiotensin	BG
-	IG
converting	IG
enzyme-10	IG
polymorphisms	O
and	O
the	O
degree	O
of	O
myocardial	BP
hypertrophy-17	IP
.	O

PS3125	O
Using	O
a	O
Cox	O
proportional	O
hazards	O
model	O
,	O
we	O
found	O
that	O
the	O
homozygous	O
c	BG
.	IG
689	IG
_	IG
690insT	IG
mutation-18	IG
was	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
onset	O
of	O
gait	BP
disturbance-29	IP
(	O
adjusted	O
hazard	O
ratio	O
:	O
6	O
.	O
60	O
)	O
and	O
for	O
the	O
inability	O
to	O
walk	O
without	O
assistance	O
(	O
adjusted	O
hazard	O
ratio	O
:	O
2	O
.	O
99	O
)	O
.	O

PS3136	O
Our	O
results	O
suggest	O
that	O
the	O
genotypes	O
of	O
GSTM1-8	BG
are	O
associated	O
with	O
cancer	O
occurrence	O
in	O
Korean	BP
Hereditary	IP
non	IP
-	IP
polyposis	IP
colorectal	IP
cancer-21	IP
family	O
members	O
carrying	O
the	O
hMLH1	IG
/	IG
hMSH2	IG
mutation	IG
.	O

PS3137	O
Although	O
evidence	O
that	O
GST	BG
genotypes-5	IG
are	O
associated	O
with	O
increased	O
cancer-10	BP
risk	O
has	O
often	O
been	O
controversial	O
,	O
the	O
genotyping	O
of	O
GSTM1-20	BG
could	O
have	O
implications	O
for	O
genetic	O
counseling	O
and	O
the	O
management	O
of	O
mismatch	BG
repair	IG
gene	IG
mutation	IG
carriers-35	IG
.	O

PS3145	O
Mutations	O
in	O
the	O
PCDH15	BG
gene-5	IG
are	O
responsible	O
for	O
Usher	O
syndrome	O
type	O
I	O
(	O
USH1F	O
)	O
and	O
non	O
-	O
syndromic	O
hearing	BP
loss-21	IP
(	O
DFNB23	O
)	O
.	O

PS3161	O
Severe	O
autoimmune	BP
enteropathy-3	IP
,	O
which	O
is	O
often	O
associated	O
with	O
increased	O
IgE-11	BG
levels	O
and	O
eosinophilia-14	BP
,	O
is	O
the	O
most	O
prominent	O
early	O
manifestation	O
of	O
IPEX	O
syndrome	O
.	O

PS3177	O
Mutations	O
in	O
cardiac	O
troponin	BG
T-5	IG
are	O
associated	O
with	O
a	O
mild	O
degree	O
of	O
hypertrophy-13	BP
,	O
but	O
a	O
high	O
incidence	O
of	O
sudden	BP
cardiac	IP
death-22	IP
.	O

PS3178	O
Mutations	O
in	O
myosin	BG
binding	IG
protein	IG
C-6	IG
are	O
associated	O
with	O
mild	O
hypertrophy-11	BP
and	O
a	O
benign	O
prognosis	O
.	O

PS3198	O
Previously	O
,	O
we	O
demonstrated	O
that	O
Ath1-6	BG
is	O
a	O
quantitative	O
trait	O
locus	O
for	O
aortic	BP
fatty-14	IP
streak	O
formation	O
,	O
located	O
on	O
Chromosome	O
1	O
,	O
with	O
susceptibility	O
in	O
C57BL	O
/	O
6J	O
mice	O
and	O
resistance	O
in	O
C3H	O
/	O
HeJ	O
and	O
BALB	O
/	O
cJ	O
mice	O
fed	O
an	O
atherogenic	O
diet	O
.	O

PS3203	O
Expression	O
of	O
FOXP1-3	BG
was	O
higher	O
in	O
familial	O
breast	BP
cancers-9	IP
(	O
54	O
%	O
)	O
compared	O
with	O
sporadic	BP
cancers-17	IP
(	O
46	O
%	O
)	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

PS3220	O
LOC387715	BG
rs10490924-2	IG
was	O
associated	O
with	O
polypoidal	O
choroidal	O
vasculopathy-8	BP
and	O
its	O
clinical	O
manifestations	O
,	O
and	O
showed	O
a	O
discrepant	O
distribution	O
between	O
polypoidal	O
choroidal	O
vasculopathy-22	BP
and	O
age	O
-	O
related	O
macular	O
degeneration	O
.	O

PS3236	O
We	O
conclude	O
that	O
axonal	O
polyneuropathy-5	BP
is	O
often	O
associated	O
with	O
ADCA	BG
type	IG
I-12	IG
,	O
but	O
its	O
frequency	O
varies	O
according	O
to	O
factors	O
such	O
as	O
the	O
locus	O
responsible	O
and	O
the	O
number	O
of	O
CAG	O
repeats	O
.	O

PS3241	O
Human	O
autoimmune	BP
lymphoproliferative-3	IP
syndrome	O
is	O
caused	O
by	O
defective	O
CD95-9	BG
-	O
mediated	O
apoptosis	O
of	O
lymphocytes	O
.	O

PS3251	O
Proximal	O
myotonic	O
myopathy	O
/	O
myotonic	BP
dystrophy-6	IP
type	O
2	O
(	O
PROMM	O
/	O
DM	O
2	O
)	O
is	O
caused	O
by	O
an	O
expansion	O
of	O
the	O
(	O
TG	O
)	O
n	O
(	O
TCTG	O
)	O
n	O
(	O
CCTG	O
)	O
n	O
repeat	O
tract	O
in	O
intron	O
1	O
of	O
the	O
ZNF9	BG
gene-42	IG
located	O
on	O
chromosome	O
3q21	O
.	O

PS3252	O
Phenylketonuria-1	BP
results	O
from	O
mutations	O
in	O
the	O
phenylalanine	BG
hydroxylase-8	IG
gene	O
.	O

PS3271	O
Anti	BG
-	IG
Saccharomyces	IG
cerevisiae	IG
antibodies-52	IG
were	O
more	O
common	O
in	O
Crohn	O
'	O
s	O
disease	O
than	O
in	O
ulcerative	BP
colitis-64	IP
(	O
40	O
/	O
70	O
(	O
57	O
%	O
)	O
twins	O
v	BG
5	IG
/	IG
43-77	IG
(	O
12	O
%	O
)	O
twins	O
)	O
.	O

PS3274	O
Alterations	O
at	O
band	O
6q24	O
and	O
heterozygous	O
activating	O
mutations	O
in	O
KCNJ11-10	BG
,	O
the	O
gene	O
encoding	O
the	O
pore	O
-	O
forming	O
subunit	O
of	O
the	O
KATP	O
channel	O
,	O
can	O
cause	O
neonatal	BP
diabetes-28	IP
.	O

PS3280	O
In	O
our	O
cohort	O
,	O
the	O
absence	O
of	O
the	O
rare	BG
IL1B	IG
+	IG
3954	IG
gene-13	IG
polymorphism	O
was	O
associated	O
with	O
juvenile	O
idiopathic	O
arthritis-20	BP
,	O
but	O
without	O
specificity	O
to	O
particular	O
disease	O
phenotypes	O
.	O

PS3285	O
Defects	O
in	O
the	O
CYP21A2	BG
gene-5	IG
cause	O
steroid	BG
21	IG
-	IG
hydroxylase-10	IG
deficiency	O
,	O
which	O
is	O
the	O
most	O
frequent	O
cause	O
of	O
congenital	BP
adrenal	IP
hyperplasia-22	IP
.	O

PS3291	O
Mutations	O
in	O
the	O
LMNA	BG
gene-5	IG
cause	O
a	O
variety	O
of	O
disorders	O
including	O
dilated	BP
cardiomyopathy-13	IP
,	O
muscular	BP
dystrophy-16	IP
,	O
familial	BP
lipodystrophy-19	IP
,	O
progeria	O
,	O
atypical	O
progeroid	O
syndromes	O
,	O
and	O
mandibuloacral	O
dysplasia	O
.	O

PS3342	O
Dystrophic	O
epidermolysis	BP
bullosa	IP
pruriginosa-4	IP
is	O
caused	O
by	O
either	O
dominant	O
or	O
recessive	O
mutations	BG
in	BG
the	BG
COL7A1	IG
gene	IG
encoding	IG
type	IG
VII	IG
collagen-20	IG
.	O

PS3352	O
Regarding	O
candidate	O
genes	O
,	O
no	O
association	O
was	O
evidenced	O
between	O
asthma-10	BP
and	O
the	O
AF508	O
mutation	O
of	O
the	O
cystic	BG
fibrosis	IG
gene-19	IG
.	O

PS3366	O
Mutations	O
in	O
the	O
mineralocorticoid	BG
receptor	IG
gene-6	IG
cause	O
Autosomal	O
dominant	O
pseudohypoaldosteronism-10	BP
type	O
1	O
,	O
but	O
the	O
long	O
-	O
term	O
consequences	O
of	O
mineralocorticoid	BG
receptor	IG
gene-23	IG
deficiency	O
in	O
humans	O
are	O
not	O
known	O
.	O

PS3367	O
Herein	O
are	O
described	O
six	O
novel	O
Autosomal	O
dominant	O
pseudohypoaldosteronism-8	BP
type	O
1	O
-	O
causing	O
mineralocorticoid	O
receptor	O
gene	O
mutations	O
(	O
four	O
de	O
novo	O
)	O
and	O
evidence	O
that	O
haploinsufficiency	O
of	O
mineralocorticoid	BG
receptor	IG
gene-29	IG
is	O
sufficient	O
to	O
cause	O
Autosomal	O
dominant	O
pseudohypoaldosteronism-36	BP
type	O
1	O
.	O

PS3369	O
Cystic	BP
fibrosis-2	IP
is	O
mainly	O
caused	O
by	O
mutations	O
that	O
interfere	O
with	O
the	O
biosynthetic	O
folding	O
of	O
the	O
cystic	BG
fibrosis	IG
transmembrane	IG
conductance	IG
regulator-20	IG
chloride	O
channel	O
.	O

PS3371	O
Our	O
case	O
provides	O
evidence	O
that	O
the	O
gene	O
dosage	O
effect	O
of	O
the	O
NSD1	BG
gene-13	IG
causes	O
a	O
reversed	O
phenotype	O
of	O
microcephaly	O
and	O
short	BP
stature-22	IP
.	O

PS415	O
While	O
a	O
clear	O
genotype	O
/	O
phenotype	O
correlation	O
has	O
not	O
been	O
established	O
,	O
mutations	O
of	O
GABRB3-15	BG
and	O
GABRA1-17	BG
are	O
associated	O
with	O
childhood	O
absence	O
epilepsy-1	BP
or	O
juvenile	O
myoclonic	O
epilepsy-2	BP
while	O
mutations	O
and	O
variants	O
of	O
GABRG2-33	BG
and	O
GABRD-35	BG
are	O
associated	O
with	O
febrile	O
seizures-40	BP
,	O
febrile	O
seizures-43	BP
with	O
childhood	O
absence	O
epilepsy-3	BP
,	O
GEfebrile	O
seizures-50	BP
+	O
,	O
and	O
Dravet	O
syndrome	O
.	O

PS1638	O
Two	O
BRCA1	BG
unclassified	IG
genetic	IG
variants-5	IG
(	O
missense	O
mutations	O
)	O
were	O
detected	O
in	O
two	O
of	O
the	O
three	O
(	O
66	O
.	O
7	O
%	O
)	O
male	O
breast	BP
cancer-25	IP
patients	O
analyzed	O
,	O
while	O
the	O
third	O
one	O
was	O
identified	O
in	O
a	O
sporadic	O
(	O
low	O
-	O
risk	O
)	O
breast	BP
cancer-44	IP
patient	O
.	O

PS2443	O
Melanomas	O
were	O
diagnosed	O
only	O
in	O
mutation	O
carriers	O
,	O
and	O
melanoma-10	BP
diagnosis	O
was	O
statistically	O
correlated	O
to	O
the	O
presence	O
of	O
one	O
or	O
more	O
clinically	O
atypical	O
nevi	O
and	O
red	O
hair	O
colour	O
,	O
supporting	O
the	O
possible	O
synergistic	O
effect	O
of	O
a	O
MC1R	BG
mutation	IG
on	O
increased	O
risk	O
of	O
melanoma-43	BP
in	O
patients	O
with	O
a	O
CDKN2A-48	BG
mutation	O
.	O

PS3610	O
Moreover	O
,	O
we	O
have	O
identified	O
novel	O
candidate	O
risk	O
alleles	O
and	O
genotypes	O
,	O
within	O
CAPN10	BG
gene-15	IG
,	O
that	O
could	O
be	O
associated	O
with	O
important	O
phenotypic	O
and	O
prognosis	O
differences	O
observed	O
in	O
polycystic	BP
ovarian-30	IP
syndrome	O
patients	O
.	O

PS3393	O
Dihydropyrimidine	BG
dehydrogenase	IG
deficiency-3	IP
causes	O
an	O
inborn	O
error	O
of	O
metabolism	O
called	O
thymine	O
-	O
uraciluria	O
that	O
is	O
in	O
some	O
instances	O
associated	O
with	O
convulsive	O
disorders	O
and	O
developmental	BP
delay-25	IP
in	O
children	O
.	O

PS3404	O
Mutations	BG
of	IG
the	IG
telomeric	IG
survival	IG
motor	IG
neuron	IG
gene	IG
(	O
SMN1-10	O
)	O
are	O
related	O
to	O
spinal	BP
muscular	IP
atrophy-17	IP
.	O

PS3408	O
Both	O
multiple	BP
endocrine	IP
neoplasia	IP
type	IP
2A-6	IP
and	O
familial	O
medullary	O
thyroid	BP
carcinoma-11	IP
are	O
caused	O
by	O
germline	BG
mutations	IG
of	IG
the	IG
RET	IG
proto	IG
-	IG
oncogene-22	IG
.	O

PS3435	O
It	O
was	O
demonstrated	O
that	O
filaggrin-5	BG
mutations	O
are	O
closely	O
associated	O
with	O
atopic	BP
eczema-12	IP
in	O
the	O
Japanese	O
population	O
.	O

PS3443	O
Adenosine	BG
deaminase-2	IG
deficiency	O
causes	O
lymphopenia-5	BP
and	O
immunodeficiency	O
due	O
to	O
toxic	O
effects	O
of	O
its	O
substrates	O
.	O

PS3466	O
It	O
is	O
,	O
however	O
,	O
unclear	O
whether	O
apolipoprotein	BG
E	IG
gene-10	IG
polymorphism	O
is	O
also	O
associated	O
with	O
increased	O
risk	O
of	O
type	O
2	O
diabetes	BP
mellitus-22	IP
.	O

PS3482	O
The	O
distributions	O
of	O
the	O
SMN2	BG
gene-6	IG
copy	O
number	O
are	O
various	O
in	O
different	O
types	O
of	O
spinal	BP
muscular	IP
atrophy-17	IP
patients	O
.	O

PS3495	O
The	O
SNP	BG
rs7216389-3	IG
,	O
which	O
tags	O
the	O
3	O
'	O
flanking	O
region	O
of	O
ORMDL3	O
at	O
17q21	O
and	O
has	O
been	O
associated	O
with	O
childhood	O
asthma-22	BP
,	O
was	O
correlated	O
with	O
increased	BP
glioma	IP
risk-29	IP
(	O
OR	O
=	O
1	O
.	O
10	O
;	O
95	O
%	O
CI	O
:	O
1	O
.	O
01	O
-	O
1	O
.	O
19	O
)	O
.	O

PS3500	O
High	BG
factor	IG
VIII-3	IG
plasma	O
levels	O
have	O
been	O
shown	O
to	O
represent	O
a	O
common	O
increased	O
risk	O
for	O
venous	BP
thromboembolism-17	IP
and	O
may	O
cause	O
an	O
activated	O
protein	O
C	O
resistance	O
in	O
the	O
absence	O
of	O
the	O
factor	BG
V	IG
Leiden	IG
mutation-34	IG
,	O
but	O
there	O
are	O
no	O
studies	O
specifically	O
aimed	O
to	O
establish	O
if	O
high	O
factor	BG
VIII-48	IG
and	O
von	BG
Willebrand	IG
factor-52	IG
concentrations	O
may	O
influence	O
the	O
activated	O
protein	BG
C	IG
sensitivity	IG
ratio-61	IG
and	O
increase	O
the	O
risk	O
for	O
venous	O
thromboembolism	O
in	O
the	O
presence	O
of	O
the	O
factor	BG
V	IG
Leiden	IG
mutation-77	IG
.	O

PS3504	O
Germline	O
mutations	O
of	O
the	O
adenomatous	BG
polyposis	IG
coli	IG
gene-8	IG
are	O
responsible	O
for	O
familial	BP
adenomatous	IP
polyposis-14	IP
.	O

PS3510	O
Several	O
point	O
mutations	BG
in	IG
the	IG
GnRH	IG
receptor	IG
gene-8	IG
have	O
been	O
described	O
in	O
an	O
autosomal	O
recessive	O
form	O
of	O
congenital	BP
isolated	IP
hypogonadotropic	IP
hypogonadism-21	IP
.	O

PS3520	O
The	O
three	O
variations	O
of	O
the	O
ITGB1BP2	BG
gene-7	IG
have	O
been	O
detected	O
in	O
families	O
of	O
patients	O
affected	O
either	O
by	O
hypertension-18	BP
or	O
primary	O
hypertrophic	BP
cardiomyopathy-22	IP
;	O

PS3528	O
In	O
conclusion	O
,	O
our	O
data	O
indicate	O
that	O
the	O
pathogenesis	O
of	O
different	O
inherited	O
and	O
acquired	O
muscle	BP
disorders-16	IP
involves	O
annexin-18	BG
overexpression	O
,	O
probably	O
because	O
these	O
proteins	O
actively	O
participate	O
in	O
the	O
plasmalemma	O
repair	O
process	O
.	O

PS3534	O
Recently	O
,	O
aberrant	O
miRNA	O
expression	O
has	O
been	O
observed	O
in	O
Cystic	O
Fibrosis	O
(	O
CF	O
)	O
,	O
an	O
autosomal	O
-	O
recessive	O
genetic	BP
disorder-21	IP
caused	O
by	O
mutations	O
in	O
the	O
CFTR	BG
gene-28	IG
,	O
in	O
which	O
a	O
genotype	O
-	O
phenotype	O
correlation	O
is	O
not	O
always	O
found	O
.	O

PS3535	O
Adult	O
-	O
type	O
hypolactasia-4	BP
is	O
characterized	O
by	O
the	O
inability	O
to	O
digest	O
lactose	O
during	O
adulthood	O
,	O
due	O
to	O
lactase-18	BG
deficiency	O
.	O

PS3540	O
The	O
frequency	O
of	O
the	O
second	O
variant	O
H63D-7	BG
is	O
also	O
increased	O
in	O
hemochromatosis-12	BP
patients	O
but	O
its	O
penetrance	O
is	O
probably	O
not	O
complete	O
.	O

PS3550	O
Heterozygous	O
mutations	O
of	O
the	O
gene	O
encoding	O
neutrophil	BG
elastase-8	IG
(	O
ELA2-10	BG
)	O
have	O
been	O
associated	O
with	O
cyclic	O
neutropenia-17	BP
and	O
severe	O
congenital	BP
neutropenia-21	IP
.	O

PS3551	O
Genotype	O
-	O
phenotype	O
analysis	O
strongly	O
suggested	O
that	O
ELA2-8	BG
mutations	O
correlate	O
with	O
more	O
severe	O
expression	O
of	O
neutropenia-16	BP
,	O
specifically	O
in	O
patients	O
diagnosed	O
with	O
Scyclic	O
neutropenia	O
.	O

PS3553	O
X	O
-	O
linked	O
adrenoleukodystrophy-4	BP
is	O
caused	O
by	O
mutations	O
in	O
the	O
ABCD1	BG
gene-12	IG
,	O
but	O
no	O
genotype	O
-	O
phenotype	O
correlation	O
has	O
been	O
established	O
so	O
far	O
and	O
modifier	O
gene	O
variants	O
are	O
suspected	O
to	O
modulate	O
phenotypes	O
.	O

PS3567	O
Major	O
components	O
of	O
MEN	BG
-	IG
2-6	IG
comprise	O
medullary	O
thyroid	BP
carcinoma-10	IP
,	O
pheochromocytoma-12	BP
,	O
and	O
primary	O
hyperparathyroidism-16	BP
.	O

PS3578	O
We	O
have	O
defined	O
molecular	O
mechanisms	O
by	O
which	O
nondeath	O
domain	O
FAS	O
mutations	O
result	O
in	O
reduced	O
lymphocyte	O
apoptosis	O
,	O
established	O
a	O
hierarchy	O
of	O
genotype	O
-	O
phenotype	O
correlation	O
among	O
mutation	O
-	O
positive	O
relatives	O
of	O
patients	O
with	O
autoimmune	BP
lymphoproliferative-35	IP
syndrome	O
,	O
and	O
demonstrated	O
that	O
FAS-41	BG
haploinsufficiency	O
can	O
lead	O
to	O
autoimmune	BP
lymphoproliferative-47	IP
syndrome	O
.	O

PS3584	O
Previous	O
studies	O
have	O
revealed	O
that	O
piebaldism-6	BP
is	O
caused	O
by	O
mutations	O
of	O
the	O
KIT	BG
gene-14	IG
,	O
which	O
encodes	O
the	O
cell	O
surface	O
transmembrane	O
tyrosine	O
kinase	O
receptor	O
for	O
KIT	O
ligand	O
.	O

PS3587	O
Inactivating	O
mutations	O
of	O
the	O
human	BG
LH	IG
receptor-7	IG
lead	O
to	O
Leydig	O
cell	O
hypoplasia-12	BP
,	O
a	O
form	O
of	O
male	BP
pseudohermaphroditism	IP
resulting	O
from	O
the	O
failure	O
of	O
fetal	O
testicular	O
Leydig	O
cell	O
differentiation	O
.	O

M4	O
in	O
the	O
clinic	O
,	O
the	O
expression	O
of	O
major	BG
histocompatibility	IG
complex-10	IG
class	O
ii	O
on	O
colorectal	BP
carcinomas-15	IP
is	O
correlated	O
with	O
more	O
favourable	O
prognosis	O
.	O

M21	O
we	O
found	O
that	O
protein	BG
kinase	IG
c	IG
activators-7	IG
rescued	O
high	O
levels	O
of	O
major	O
histocompatibility	O
complex	O
class	O
ii	O
expression	O
in	O
colon	BP
carcinoma-20	IP
cells	O
and	O
failed	O
to	O
do	O
so	O
in	O
mesothelioma-28	BP
and	O
hepatocellular	BP
carcinoma-31	IP
cells	O
.	O

M43	O
We	O
demonstrate	O
that	O
heterozygous	O
deficiency	O
of	O
bmp4-8	BG
results	O
in	O
anterior	BP
segment	IP
dysgenesis-13	IP
and	O
elevated	O
intraocular	O
pressure	O
.	O

M54	O
No	O
esr1	BG
snp-4	IG
was	O
associated	O
with	O
obesity-8	BP
.	O

M56	O
a	O
minor	O
importance	O
of	O
esr2-5	BG
on	O
severe	O
obesity-8	BP
cannot	O
be	O
excluded	O
.	O

M57	O
defining	O
gene	BG
alleles-3	IG
that	O
are	O
associated	O
with	O
obesity-8	BP
will	O
contribute	O
to	O
our	O
understanding	O
of	O
the	O
underlying	O
mechanisms	O
behind	O
its	O
development	O
and	O
potentially	O
provide	O
therapeutic	O
targets	O
.	O

M58	O
furthermore	O
,	O
neither	O
rs2234693-4	BG
nor	O
rs9340799-6	BG
was	O
associated	O
with	O
obesity-10	BP
in	O
swedish	O
women	O
[	O
16	O
]	O
.	O

M70	O
esr2	BG
snp	IG
rs4986938-3	IG
was	O
associated	O
with	O
obesity-7	BP
in	O
men	O
only	O
,	O
nominal	O
p	O
value	O
0	O
.	O
05	O
.	O

M72	O
in	O
sample	O
1	O
,	O
no	O
esr1	BG
haplotype-7	IG
was	O
associated	O
with	O
obesity-11	BP
,	O
table	O
3	O
.	O

M76	O
two	O
esr2	BG
single	IG
nucleotide	IG
polymorphisms	IG
,	IG
rs7154455	IG
and	IG
rs3020450-9	IG
were	O
associated	O
with	O
obesity-13	BP
with	O
nominal	O
p	O
value	O
<	O
0	O
.	O
01	O
.	O

M83	O
in	O
dogs	O
cystatin	BG
-	IG
c-5	IG
concentration	O
seemed	O
to	O
correlate	O
with	O
s	O
-	O
creatinine	O
concentrations	O
in	O
chronic	BP
renal	IP
failure-18	IP
,	O
although	O
that	O
correlation	O
was	O
not	O
as	O
good	O
with	O
volume	O
-	O
depleted	O
dogs	O
[	O
12	O
]	O
.	O

M108	O
the	O
only	O
report	O
on	O
survivin-5	BG
expression	O
in	O
osteosarcoma-8	BP
used	O
immunohistochemistry	O
.	O

M109	O
survivin-1	BG
expression	O
is	O
also	O
reportedly	O
a	O
useful	O
prognostic	O
marker	O
in	O
osteosarcoma-11	BP
,	O
and	O
patients	O
showing	O
survivin	O
expression	O
could	O
potentially	O
benefit	O
from	O
optimal	O
selection	O
of	O
neoadjuvant	O
chemotherapy	O
[	O
25	O
]	O
.	O

M120	O
consequently	O
,	O
the	O
skp2-4	BG
pathway	O
may	O
be	O
a	O
suitable	O
target	O
for	O
novel	O
prostate	BP
cancer-14	IP
therapies	O
.	O

M125	O
in	O
fact	O
,	O
p27-4	BG
depletion	O
in	O
several	O
cancers-8	BP
was	O
shown	O
to	O
result	O
from	O
increased	O
proteolysis	O
via	O
the	O
ubiquitin-18	BG
/	O
proteasome	O
system	O
.	O

M150	O
adiponectin-1	BG
levels	O
increase	O
with	O
weight	BP
loss-6	IP
and	O
with	O
use	O
of	O
insulin-11	BG
sensitizing	O
drugs	O
.	O

M158	O
nevoid	O
basal	BP
cell	IP
carcinoma-4	IP
syndrome	O
is	O
caused	O
by	O
mutations	O
in	O
the	O
ptch1	BG
gene-13	IG
and	O
is	O
transmitted	O
as	O
an	O
autosomal	O
dominant	O
trait	O
with	O
complete	O
penetrance	O
and	O
variable	O
expressivity	O
.	O

M162	O
a	O
recent	O
study	O
has	O
reported	O
that	O
certain	O
haplotypes	O
of	O
ptch1-10	BG
polymorphisms	O
may	O
mediate	O
the	O
susceptibility	O
to	O
basal	BP
cell	IP
carcinomas-19	IP
[	O
132	O
]	O
.	O

M192	O
levels	O
of	O
both	O
rsu1	BG
mrna	IG
and	IG
protein-7	IG
have	O
been	O
correlated	O
with	O
a	O
decrease	O
in	O
growth	O
rate	O
and	O
tumorigenic	O
potential	O
in	O
u251	O
glioblastoma-22	BP
cells	O
and	O
it	O
induces	O
growth	O
arrest	O
in	O
pc12	O
cells	O
.	O

M195	O
bnip3l-1	BG
,	O
encoding	O
bcl2-4	BG
/	O
adenovirus	O
e1b	O
19	O
kd	O
-	O
interacting	O
protein	O
3	O
-	O
like	O
,	O
is	O
a	O
pro	O
-	O
apoptotic	O
gene	O
which	O
has	O
a	O
growth	O
-	O
inhibitory	O
effect	O
on	O
cancer-31	BP
cells	O
.	O

M196	O
cdh13-1	BG
,	O
encoding	O
cadherin	BG
13-5	IG
,	O
is	O
significantly	O
downregulated	O
in	O
human	O
breast	BP
carcinoma-13	IP
cell	O
lines	O
and	O
breast	BP
cancer-18	IP
,	O
whereas	O
its	O
overexpression	O
decreases	O
tumor	O
-	O
cell	O
growth	O
.	O

M205	O
elevated	O
circulating	O
tumour	BG
necrosis	IG
factor	IG
-	IG
a-7	IG
levels	O
are	O
associated	O
with	O
obesity-12	BP
and	O
insulin	BP
resistance-15	IP
both	O
in	O
animal	O
models	O
and	O
humans	O
[	O
40	O
,	O
41	O
]	O
.	O

M210	O
leptin-1	BG
levels	O
were	O
initially	O
found	O
to	O
be	O
significantly	O
higher	O
in	O
47	O
non	O
-	O
alcoholic	O
steatohepatitis	O
patients	O
than	O
47	O
controls	O
and	O
correlated	O
with	O
the	O
severity	O
of	O
hepatic	BP
steatosis-27	IP
but	O
not	O
of	O
necroinflammation	O
or	O
fibrosis	O
[	O
69	O
]	O
.	O

M217	O
the	O
measurement	O
of	O
high	O
molecular	O
weight	O
adiponectin-7	BG
levels	O
,	O
which	O
are	O
thought	O
to	O
better	O
correlate	O
with	O
steatosis-17	BP
than	O
the	O
total	O
adiponectin-21	BG
levels	O
[	O
79	O
]	O
and	O
the	O
validation	O
of	O
these	O
markers	O
in	O
larger	O
cohorts	O
would	O
be	O
crucial	O
steps	O
towards	O
the	O
widespread	O
use	O
of	O
these	O
biomarker	O
panels	O
.	O

M225	O
in	O
a	O
study	O
of	O
36	O
morbidly	O
obese	O
patients	O
and	O
12	O
healthy	O
controls	O
,	O
interleukin	BG
-	IG
6-16	IG
was	O
an	O
independent	O
predictor	O
of	O
steatosis-22	BP
and	O
non	O
-	O
alcoholic	O
steatohepatitis	O
[	O
89	O
]	O
.	O

M228	O
mutations	O
in	O
the	O
limbin	BG
gene-5	IG
,	O
a	O
bovine	O
orthologue	O
of	O
ellis	O
-	O
van	O
creveld	O
syndrome2	O
,	O
are	O
associated	O
with	O
bovine	O
chondrodysplastic	O
dwarfism-22	BP
[	O
28	O
]	O
.	O

M231	O
more	O
recently	O
,	O
telomerase	BG
reverse	IG
transcriptase-6	IG
gene	O
mutations	O
have	O
been	O
identified	O
in	O
rare	O
individuals	O
with	O
autosomal	O
dominant	O
dyskeratosis	O
congenita	O
and	O
in	O
sporadic	O
cases	O
of	O
bone	BP
marrow	IP
failure-27	IP
(	O
armanios	O
et	O
al	O
.	O
,	O
2005	O
;	O
vulliamy	O
et	O
al	O
.	O
,	O
2005	O
;	O
yamaguchi	O
et	O
al	O
.	O
,	O
2005	O
;	O
liang	O
et	O
al	O
.	O
,	O
2006	O
;	O
vulliamy	O
&	O
dokal	O
,	O
2006	O
;	O
xin	O
et	O
al	O
.	O
,	O
2007	O
)	O
.	O

M301	O
other	O
studies	O
indicated	O
that	O
levels	O
of	O
secretory	O
leukocyte	BG
protease-9	IG
inhibitor	O
are	O
also	O
lower	O
in	O
nasal	O
secretion	O
of	O
allergic	BP
rhinitis-19	IP
patients	O
compared	O
to	O
healthy	O
controls	O
.	O

M305	O
however	O
,	O
it	O
has	O
been	O
suggested	O
that	O
reduced	BP
renal	IP
function-10	IP
can	O
cause	O
an	O
increase	O
in	O
cardiac	O
-	O
specific	O
troponin	BG
i-20	IG
in	O
the	O
absence	O
of	O
myocardial	O
cell	O
damage	O
[	O
21	O
]	O
.	O

M307	O
logistic	O
analysis	O
revealed	O
a	O
significant	O
association	O
of	O
apolipoproteinc3	BG
s2	IG
allele-10	IG
with	O
hypertriglyceridemia-12	BP
(	O
table	O
3	O
)	O
.	O

M308	O
various	O
restriction	O
fragment	O
length	O
polymorphisms	O
in	O
and	O
around	O
the	O
human	BG
apolipoproteinc3gene-11	IG
have	O
been	O
associated	O
with	O
hypertriglyceridemia-16	BP
in	O
several	O
distinct	O
populations	O
.	O

M309	O
ours	O
is	O
the	O
first	O
study	O
on	O
asian	O
indians	O
to	O
report	O
a	O
strong	O
association	O
of	O
apolipoproteinc3s2	BG
allele-16	IG
with	O
hypertriglyceridemia-18	BP
in	O
indians	O
.	O

M327	O
calpain	BG
5	IG
gene-3	IG
has	O
been	O
previously	O
associated	O
with	O
polycystic	BP
ovary-10	IP
syndrome	O
by	O
our	O
group	O
.	O

M331	O
in	O
humans	O
,	O
the	O
fem1a	BG
gene-6	IG
maps	O
to	O
chromosome	O
19p13	O
.	O
3	O
,	O
a	O
region	O
linked	O
to	O
polycystic	BP
ovary-19	IP
syndrome	O
,	O
a	O
common	O
endocrine	O
disorder	O
of	O
women	O
of	O
reproductive	O
age	O
,	O
characterized	O
by	O
chronic	O
anovulation	O
,	O
infertility-42	BP
,	O
hyperandrogenemia	O
and	O
frequently	O
,	O
insulin	BG
resistance-49	IP
resulting	O
in	O
an	O
increased	O
prevalence	O
of	O
obesity-56	BP
,	O
cardiovascular	BP
disease-59	IP
and	O
type	O
2	O
diabetes	BP
mellitus-64	IP
,	O
reason	O
why	O
polycystic	O
ovary	O
syndrome	O
is	O
consider	O
a	O
phenotype	O
closely	O
related	O
to	O
metabolic	O
syndrome	O
.	O

M348	O
this	O
region	O
only	O
includes	O
the	O
gene	O
that	O
codifies	O
b3gn	BG
-	IG
t6-11	IG
,	O
a	O
member	O
of	O
the	O
n	BG
-	IG
acetylglucosaminyl	IG
transferase	IG
protein	IG
family-22	IG
related	O
to	O
muscular	BP
dystrophies-26	IP
,	O
neoplastic	O
disorders	O
and	O
altered	O
glucose	O
homeostasis	O
,	O
although	O
b3gn	BG
-	IG
t6-38	IG
has	O
never	O
been	O
analysed	O
in	O
humans	O
[	O
45	O
]	O
.	O

M371	O
the	O
two	O
common	O
pathogenic	O
mutations	BG
in	IG
nd6-7	IG
(	O
met64	BG
val-10	IG
and	O
ala72	BG
val-13	IG
)	O
lead	O
to	O
a	O
less	O
severe	O
and	O
a	O
very	O
severe	O
form	O
of	O
leber	O
'	O
s	O
hereditary	O
optic	BP
neuropathy-31	IP
,	O
respectively	O
.	O

M404	O
Acetylcholinesterase-3	BG
inhibitors	O
slow	O
the	O
hydrolysis	O
of	O
acetylcholine	O
at	O
the	O
neuromuscular	O
junction	O
and	O
provide	O
temporary	O
improvement	O
in	O
strength	O
in	O
many	O
patients	O
with	O
myasthenia-24	BP
gravis	O
.	O

M406	O
acetylcholinesterase-1	BG
inhibitors	O
are	O
a	O
symptomatic	O
therapy	O
for	O
myasthenia-8	BP
gravis	O
and	O
do	O
not	O
retard	O
the	O
underlying	O
autoimmune	O
attack	O
on	O
the	O
neuromuscular	O
junction	O
.	O

M408	O
effective	O
dosing	O
of	O
acetylcholinesterase-4	BG
inhibitors	O
reduces	O
myasthenic	BP
weakness-8	IP
,	O
minimizes	O
muscarinic	O
medication	O
side	O
effects	O
,	O
and	O
must	O
be	O
individualized	O
to	O
each	O
patient	O
'	O
s	O
distribution	O
of	O
weakness	O
and	O
diurnal	O
symptom	O
fluctuation	O
.	O

S15	O
Thus	O
,	O
aP2-3	BG
regulates	O
allergic	BP
airway	IP
inflammation-7	IP
and	O
may	O
provide	O
a	O
link	O
between	O
fatty	O
acid	O
metabolism	O
and	O
asthma	BP
.	O 

S54	O
A	O
stop	BG
codon-3	IG
polymorphism	IG
of	IG
Toll	IG
-	IG
like	IG
receptor	IG
5-10	IG
is	O
associated	O
with	O
resistance	O
to	O
systemic	BG
lupus	IG
erythematosus	IG
.	O 

S58	O
Together	O
,	O
these	O
results	O
indicate	O
that	O
the	O
TLR5	BG
stop	IG
codon	IG
polymorphism	IG
is	O
associated	O
with	O
protection	O
from	O
the	O
development	BP
of	IP
SLE	IP
.	O 

S69	O
These	O
data	O
show	O
that	O
shed	O
A	BG
subunits-7	IG
induce	O
or	O
amplify	O
the	O
immune	O
response	O
leading	O
to	O
hyperthyroidism	BP
and	O
provide	O
new	O
insight	O
into	O
the	O
etiology	O
of	O
Graves	O
disease	O
.	O 

S84	O
Using	O
this	O
method	O
,	O
we	O
have	O
examined	O
the	O
relative	O
effects	O
of	O
HLA	BG
-	IG
DR	IG
alleles-15	IG
in	O
susceptibility	BP
to	IP
Graves	IP
disease-20	IP
in	O
the	O
Caucasian	O
population	O
.	O 

S89	O
This	O
work	O
demonstrates	O
how	O
gene-5	BG
CNV	O
and	O
its	O
related	O
polymorphisms	O
are	O
associated	O
with	O
the	O
susceptibility	BP
to	IP
a	IP
human	IP
complex	IP
disease-20	IP
.	O 

S92	O
Th	BP
cell	IP
activation	IP
,	IP
differentiation-5	IP
,	O
and	O
immune	O
function	O
are	O
regulated	O
by	O
costimulatory	BG
molecules-14	IG
.	O

S96	O
Several	O
genomewide	O
screens	O
have	O
been	O
performed	O
to	O
identify	O
novel	O
loci-10	BG
predisposing	O
to	O
unfavorable	BP
serum	IP
lipid	IP
levels-16	IP
and	O
coronary	O
heart	O
disease	O
(	O
CHD	O
)	O
.	O

S113	O
An	O
HBD	BG
-	IG
2	IG
gene-5	IG
copy	O
number	O
of	O
<	O
4	O
was	O
associated	O
with	O
diminished	BP
mucosal	IP
HBD	IP
-	IP
2	IP
mRNA	IP
expression-20	IP
(	O
P	O
=	O
.	O
033	O
)	O
.	O

S119	O
Together	O
with	O
recent	O
evidence	O
showing	O
association	O
of	O
this	O
SNP	O
with	O
type	O
1	O
diabetes	O
and	O
rheumatoid	O
arthritis	O
,	O
these	O
data	O
provide	O
compelling	O
evidence	O
that	O
PTPN22-24	BG
plays	O
a	O
fundamental	O
role	O
in	O
regulating	O
the	O
immune	O
system	O
and	O
the	O
development	O
of	O
autoimmunity-38	BP
.	O 

S122	O
Previous	O
genetic	O
studies	O
have	O
suggested	O
associations	O
with	O
HLA	BG
Class	IG
II	IG
alleles-11	IG
,	O
complement	BP
gene	IP
deficiencies-15	IP
,	O
and	O
Fc	BG
receptor-19	IG
polymorphisms	O
;	O
however	O
,	O
it	O
is	O
likely	O
that	O
other	O
genes-29	BG
contribute	O
to	O
SLE	BP
susceptibility	IP
and	IP
pathogenesis-35	IP
.	O

S123	O
These	O
data	O
support	O
the	O
hypothesis	O
that	O
multiple	O
genes-8	BG
,	O
including	O
one	O
in	O
the	O
HLA	BG
region-15	IG
,	O
influence	O
susceptibility	BP
to	IP
human	IP
SLE-21	IP
.	O 

S125	O
In	O
contrast	O
,	O
mice	O
with	O
genetic	O
deletion	O
of	O
GSNOR-9	BG
exhibit	O
increases	O
in	O
lung	BP
SNOs-14	IP
and	O
are	O
protected	O
from	O
airway	O
hyperresponsivity	O
.	O

S154	O
A	O
genome	O
-	O
wide	O
association	O
study	O
was	O
performed	O
to	O
identify	O
genetic	BG
factors-12	IG
involved	O
in	O
susceptibility	BP
to	IP
psoriasis	IP
(	IP
PS	IP
)	IP
and	IP
psoriatic	IP
arthritis	IP
(	IP
PSA	IP
)	IP
,	IP
inflammatory	IP
diseases	IP
of	IP
the	IP
skin	IP
and	IP
joints-34	IP
in	O
humans	O
.	O

S167	O
We	O
therefore	O
found	O
out	O
the	O
KIAA1109	BG
/	IG
Tenr	IG
/	IG
IL2	IG
/	IG
IL21	IG
region-15	IG
is	O
involved	O
in	O
susceptibility	BP
to	IP
multiple	IP
autoimmune	IP
diseases-23	IP
.	O 

S173	O
The	O
IgG-2	BG
bound	O
DNA-4	BG
and	O
NMDAR-6	BG
and	O
caused	O
neuronal	BP
apoptosis-10	IP
when	O
injected	O
into	O
mouse	O
brains	O
.	O

S180	O
We	O
report	O
also	O
that	O
CEACAM6-5	BG
acts	O
as	O
a	O
receptor	O
for	O
AIEC	BP
adhesion-12	IP
and	O
is	O
abnormally	O
expressed	O
by	O
ileal	O
epithelial	O
cells	O
in	O
CD	O
patients	O
.	O

S184	O
Citrullinated	O
proteins-2	BG
have	O
increased	O
immunogenicity	O
and	O
arthritogenicity	O
and	O
their	O
presence	O
in	O
arthritic	O
joints	O
correlates	O
with	O
disease	BP
severity	IP
.	O

S194	O
The	O
subphenotypes	BP
of	IP
Crohn	IP
disease	IP
,	IP
ulcerative	IP
colitis	IP
,	IP
and	IP
mixed	IP
IBD-12	IP
contributed	O
equally	O
to	O
this	O
linkage	O
,	O
suggesting	O
a	O
general	O
role	O
for	O
the	O
chromosome	BG
6	IG
locus-27	IG
in	O
IBD	BP
.	O 

S199	O
We	O
report	O
that	O
IRAK	BG
-	IG
M-6	IG
is	O
involved	O
in	O
the	O
pathogenesis	BP
of	IP
early	IP
-	IP
onset	IP
persistent	IP
asthma-17	IP
.	O

S203	O
These	O
genetic	O
data	O
,	O
combined	O
with	O
biochemical	O
evidence	O
that	O
this	O
SNP	O
affects	O
PTPN22-13	BG
function	O
,	O
suggest	O
that	O
this	O
phosphatase-19	BG
is	O
a	O
key	O
regulator	O
of	O
autoimmunity-25	BP
.	O

S204	O
Additional	O
analyses	O
identified	O
two	O
SNPs	O
on	O
a	O
single	O
common	BG
haplotype-10	IG
that	O
are	O
associated	O
with	O
RA	O
independent	O
of	O
R620W	O
,	O
suggesting	O
that	O
R620W	O
and	O
at	O
least	O
one	O
additional	BG
variant	IG
in	IG
the	IG
PTPN22	IG
gene	IG
region-33	IG
influence	O
RA	BP
susceptibility-36	IP
.	O 

S206	O
Analysis	O
of	O
Families	O
in	O
the	O
Multiple	O
Autoimmune	O
Disease	O
Genetics	O
Consortium	O
(	O
MADGC	O
)	O
Collection	O
:	O
the	O
PTPN22	BG
620W	IG
Allele-19	IG
Associates	O
with	O
Multiple	BP
Autoimmune	IP
Autoimmune-24	IP
.	O 

PS6	O
The	O
genetic	O
testing	O
for	O
the	O
C	BG
/	IG
T	IG
-	IG
13910	IG
variant-11	IG
may	O
be	O
helpful	O
in	O
the	O
diagnosis	O
of	O
adult	BP
-	IP
type	IP
hypolactasia-22	IP
in	O
Indian	O
children	O
.	O

PS8	O
Since	O
IL	BG
-	IG
18-4	IG
plays	O
a	O
major	O
role	O
in	O
perpetuating	O
hemophagocytosis-11	BP
,	O
the	O
failure	O
of	O
IFNgamma-16	BG
to	O
induce	O
IL	BG
-	IG
18	IG
binding	IG
protein-23	IG
may	O
constitute	O
a	O
fundamental	O
pathogenetic	O
mechanism	O
.	O

PS10	O
It	O
implied	O
that	O
regions	O
in	O
the	O
vicinity	O
of	O
locus	O
D8S1179-10	BG
may	O
harbor	O
susceptibility	O
genes	O
for	O
cerebral	BP
infarction-17	IP
.	O

PS14	O
We	O
used	O
homozygosity	O
mapping	O
in	O
two	O
families	O
with	O
autosomal	O
-	O
recessive	O
short	O
-	O
rib	O
polydactyly	O
syndrome	O
Majewski	O
type	O
to	O
identify	O
mutations	O
in	O
NEK1-23	IG
as	O
an	O
underlying	O
cause	O
of	O
this	O
lethal	BP
osteochondrodysplasia-31	IP
.	O

PS17	O
The	O
cystic	BG
fibrosisTR	IG
genotype-4	IG
is	O
invariably	O
correlated	O
with	O
pancreatic	O
status	O
-	O
in	O
about	O
85	O
%	O
of	O
cases	O
with	O
pancreatic	BP
insufficiency-20	IP
and	O
in	O
about	O
15	O
%	O
of	O
cases	O
with	O
pancreatic	BP
sufficiency-30	IP
.	O

PS41	O
Correlation	O
of	O
specific	O
Myelin	BG
protein-5	IG
zero	O
mutations	O
with	O
their	O
phenotypes	O
demonstrated	O
that	O
addition	O
of	O
either	O
a	O
charged	O
amino	O
acid	O
or	O
altering	O
a	O
cysteine	O
residue	O
in	O
the	O
extracellular	O
domain	O
caused	O
a	O
severe	O
early	O
onset	O
neuropathy-34	BP
.	O

PS44	O
The	O
major	O
cause	O
of	O
congenital	BP
adrenal	IP
hyperplasia-7	IP
,	O
a	O
common	O
recessive	O
genetic	O
disease	O
,	O
is	O
the	O
deficiency	O
of	O
steroid	BG
21	IG
-	IG
hydroxylase-22	IG
(	O
21OH	O
)	O
,	O
a	O
microsomal	O
enzyme	O
encoded	O
by	O
the	O
CYP21	BG
gene-34	IG
.	O

PS57	O
Fukuyama	O
-	O
type	O
Congenital	O
muscular	BP
dystrophy-6	IP
and	O
MDC1C-8	BG
are	O
caused	O
by	O
mutations	O
in	O
the	O
fukutin-15	BG
and	O
fukutin	BG
-	IG
related	IG
protein-20	IG
genes	O
,	O
respectively	O
.	O

PS65	O
Most	O
Autosomal	O
recessive	O
polycystic	BP
kidney-5	IP
disease	O
cases	O
are	O
caused	O
by	O
mutations	O
in	O
the	O
gene	O
PKHD1-15	BG
.	O

PS82	O
We	O
describe	O
for	O
the	O
first	O
time	O
a	O
form	O
of	O
secondary	O
erythrocytosis-11	BP
caused	O
by	O
compound	O
heterozygosity	O
for	O
hemoglobin-17	BG
Tak-18	BG
and	O
thalassemia	O
found	O
in	O
an	O
adult	O
Thai	O
individual	O
.	O

PS91	O
Heterozygous	O
germline	O
mutations	O
of	O
multiple	O
endocrine	BG
neoplasia	IG
type	IG
1	IG
gene-10	IG
are	O
responsible	O
for	O
multiple	O
endocrine	O
neoplasia-16	BP
type	O
1	O
disorders	O
.	O

PS108	O
Disturbance	O
in	O
the	O
adaptive	O
immune	O
system	O
,	O
in	O
particular	O
the	O
IL	BG
-	IG
23	IG
/	IG
Th17-15	IG
axis	IG
,	O
has	O
also	O
shown	O
to	O
be	O
of	O
importance	O
for	O
inflammatory	BP
bowel	IP
disease-28	IP
overall	O
.	O

PS127	O
Cystic	BP
fibrosis-2	IP
is	O
caused	O
by	O
mutations	O
in	O
the	O
transmembrane	BG
conductance	IG
regulator-11	IG
gene	O
,	O
which	O
encodes	O
an	O
important	O
chloride	O
ion	O
channel	O
.	O

PS139	O
Spinal	BP
muscular	IP
atrophy-3	IP
(	O
SMA	O
type	O
I	O
,	O
II	O
and	O
III	O
)	O
is	O
an	O
autosomal	O
recessive	O
neuromuscular	O
disorder	O
caused	O
by	O
mutations	O
in	O
the	O
survival	O
motor	O
neuron	O
gene	O
(	O
SMN1-29	BG
)	O
.	O

PS140	O
Insulin	BG
-	IG
like	IG
growth	IG
factor	IG
1-6	IG
and	O
its	O
main	O
binding	O
protein	O
,	O
IGF	BG
-	IG
binding	IG
protein	IG
3-17	IG
,	O
play	O
an	O
important	O
role	O
in	O
cancer-24	BP
development	O
.	O

PS141	O
Circulating	O
levels	O
and	O
functional	O
polymorphisms	O
of	O
Insulin	BG
-	IG
like	IG
growth	IG
factor	IG
1-12	IG
and	O
IGF	BG
-	IG
binding	IG
protein	IG
3-18	IG
may	O
be	O
biomarkers	O
of	O
cancer-23	BP
development	O
.	O

PS158	O
Hereditary	O
angioedema-2	BP
,	O
type	O
I	O
and	O
II	O
,	O
is	O
an	O
autosomal	O
dominant	O
disease	O
with	O
deficiency	O
of	O
functional	O
C1-18	BG
inhibitor	O
protein	O
causing	O
episodic	O
swellings	O
of	O
skin	O
,	O
mucosa	O
and	O
viscera	O
.	O

PS169	O
Phenylketonuria	BP
and	O
mild	O
hyperphenylalaninemia-4	BP
are	O
allelic	O
disorders	O
caused	O
by	O
mutations	O
in	O
the	O
gene	O
encoding	O
phenylalanine	BG
hydroxylase-16	IG
.	O

PS193	O
Ankyloblepharon	O
,	O
ectodermal	O
defects	O
,	O
and	O
cleft	BP
lip	IP
and	IP
palate	IP
(	O
AEC-20	BP
)	O
syndrome	O
is	O
a	O
rare	O
autosomal	O
dominant	O
disorder	O
caused	O
by	O
mutations	O
in	O
the	O
sterile	O
alpha	O
motif	O
region	O
of	O
TP63-31	BG
,	O
a	O
homologue	O
of	O
the	O
tumor	O
suppressor	O
TP53	O
.	O

PS198	O
Our	O
finding	O
that	O
the	O
presence	O
of	O
the	O
HVR3	BG
sequence-9	IG
confers	O
susceptibility	O
and	O
also	O
influences	O
the	O
clinical	O
expression	O
and	O
tempo	O
of	O
progression	O
of	O
rheumatoid	BP
arthritis-24	IP
suggests	O
a	O
role	O
in	O
pathogenesis	O
for	O
antigen	O
presentation	O
,	O
whether	O
of	O
an	O
autoantigenic	O
molecule	O
or	O
a	O
persisting	O
infection	O
.	O

PS208	O
Krabbe	O
disease	O
(	O
globoid	BP
cell	IP
leukodystrophy-6	IP
)	O
is	O
an	O
autosomal	O
recessive	O
neurodegenerative	O
disorder	O
that	O
affects	O
both	O
the	O
central	O
and	O
peripheral	O
nervous	O
system	O
due	O
to	O
an	O
enzymatic	O
defect	O
of	O
galactocerebrosidase-29	BG
.	O

PS216	O
The	O
serum	O
concentration	O
of	O
C	BG
-	IG
reactive	IG
protein-8	IG
does	O
not	O
appear	O
to	O
be	O
influenced	O
by	O
the	O
functional	O
single	O
nucleotide	O
polymorphism	O
of	O
the	O
C	BG
-	IG
reactive	IG
protein	IG
gene-27	IG
,	O
which	O
also	O
appears	O
to	O
have	O
no	O
association	O
with	O
abdominal	BP
aortic	IP
aneurysm-39	IP
formation	O
.	O

PS218	O
In	O
comparison	O
to	O
wild	BG
-	IG
type	IG
P450	IG
oxidoreductase-8	IG
,	O
the	O
P399	BG
_	IG
E401del	IG
protein-14	IG
was	O
found	O
to	O
decrease	O
catalytic	BP
efficiency-20	IP
of	O
21	O
-	O
hydroxylation	O
of	O
progesterone	O
by	O
68	O
%	O
.	O

PS228	O
Taken	O
together	O
,	O
these	O
findings	O
indicate	O
that	O
the	O
miR	BG
-	IG
184	IG
binding	IG
site	IG
SNP-14	IG
(	O
rs8126	O
T	O
>	O
C	O
)	O
in	O
the	O
3	O
'	O
untranslated	O
region	O
of	O
TNFAIP2	O
is	O
functional	O
by	O
modulating	O
TNFAIP2	O
expression	O
and	O
contributes	O
to	O
squamous	BP
cell	IP
carcinoma-40	IP
of	O
the	O
head	O
and	O
neck	O
susceptibility	O
.	O

PS231	O
Friedreich	O
'	O
s	O
ataxia-4	BP
,	O
the	O
most	O
common	O
inherited	O
ataxia-10	BP
,	O
is	O
associated	O
with	O
an	O
unstable	O
expansion	O
of	O
GAA	O
repeats	O
in	O
the	O
first	O
intron	O
of	O
the	O
frataxin	BG
gene-28	IG
on	O
chromosome	O
9	O
.	O

PS283	O
Activating	O
mutations	O
in	O
the	O
Ret	BG
proto	IG
-	IG
oncogene-8	IG
are	O
responsible	O
for	O
occurrence	O
of	O
multiple	O
endocrine	O
neoplasia-16	BP
(	O
MEN	BP
)	O
type	O
2A	O
and	O
2B	O
,	O
and	O
familial	O
medullary	O
thyroid	BP
carcinoma-31	IP
.	O

PS291	O
No	O
linkage	O
was	O
found	O
between	O
UL139	BG
genotype-7	IG
and	O
clinical	O
phenotype	O
of	O
Hirschsprung	BP
'	IP
s	IP
disease-15	IP
.	O

PS316	O
In	O
patients	O
with	O
established	O
and	O
stable	O
coronary	BP
artery	IP
disease-9	IP
the	O
434SS	O
variant	O
of	O
Cytochrome	BG
P4504A11	IG
F434-16	IG
is	O
associated	O
with	O
pronounced	O
coronary	O
vasoconstriction	O
.	O

PS319	O
proteolipid	BG
protein	IG
1	IG
gene-4	IG
mutations	O
are	O
associated	O
with	O
a	O
large	O
spectrum	O
of	O
X	O
-	O
linked	O
dysmyelinating	O
disorders	O
ranging	O
from	O
hypomyelinating	BP
leukodystrophy-21	IP
,	O
Pelizaeus	O
-	O
Merzbacher	O
disease	O
,	O
to	O
spastic	BP
paraplegia-30	IP
according	O
to	O
the	O
nature	O
of	O
the	O
mutation	O
.	O

PS323	O
Moreover	O
,	O
duplication	O
of	O
the	O
MECP2-6	BG
region	O
occurs	O
frequently	O
in	O
male	O
patients	O
with	O
a	O
severe	O
form	O
of	O
mental	BP
retardation-19	IP
,	O
which	O
justifies	O
quantitative	O
screening	O
of	O
MECP2-26	BG
in	O
this	O
group	O
of	O
patients	O
.	O

PS329	O
H	O
syndrome	O
and	O
pigmented	O
hypertrichosis-5	BP
with	O
insulin	O
dependent	O
diabetes	O
are	O
allelic	O
autosomal	O
recessive	O
syndromes	O
reported	O
in	O
the	O
last	O
year	O
to	O
be	O
caused	O
by	O
mutations	O
in	O
the	O
SLC29A3	BG
gene-28	IG
,	O
which	O
encodes	O
the	O
equilibrative	O
nucleoside	O
transporter	O
hENT3	O
.	O

PS333	O
MECP2-1	BG
mutations	O
have	O
subsequently	O
been	O
identified	O
in	O
patients	O
with	O
a	O
variety	O
of	O
clinical	O
syndromes	O
ranging	O
from	O
mild	O
learning	O
disability	O
in	O
females	O
to	O
severe	O
mental	BP
retardation-25	IP
,	O
seizures-27	BP
,	O
ataxia-29	BP
,	O
and	O
sometimes	O
neonatal	BP
encephalopathy-34	IP
in	O
males	O
.	O

PS334	O
Friedreich	O
ataxia-2	BP
is	O
associated	O
with	O
the	O
expansion	O
of	O
a	O
GAA	O
trinucleotide	O
repeat	O
in	O
the	O
first	O
intron	O
of	O
the	O
X25	BG
gene-20	IG
.	O

PS351	O
This	O
distinguishes	O
Multiple	O
self	O
-	O
healing	O
squamous	O
epithelioma-8	BP
from	O
the	O
Marfan	O
syndrome	O
-	O
related	O
disorders	O
in	O
which	O
missense	O
mutations	O
in	O
TGFBR1-21	BG
lead	O
to	O
developmental	BP
defects	IP
with	IP
vascular	IP
involvement	IP
but	O
no	O
reported	O
predisposition	O
to	O
cancer-34	BP
.	O

PS352	O
Severe	O
hearing	BP
loss-3	IP
was	O
present	O
from	O
an	O
early	O
age	O
(	O
4	O
to	O
6	O
years	O
)	O
in	O
35	O
%	O
of	O
subjects	O
with	O
USH3-22	BG
.	O

PS375	O
All	O
isolates	O
expressing	O
the	O
mefA	BG
gene-6	IG
displayed	O
the	O
M	BP
phenotype	IP
whilst	O
all	O
those	O
expressing	O
ermB-15	BG
displayed	O
the	O
constitutive	BP
macrolide	IP
resistance-20	IP
(	O
cMLS	O
(	O
B	O
)	O
)	O
phenotype	O
.	O

PS403	O
The	O
CDKN2A	BG
gene-3	IG
encodes	O
the	O
cell	O
cycle	O
inhibitor	O
p16	BG
/	IG
INK4A-11	IG
,	O
which	O
is	O
involved	O
in	O
familial	O
cutaneous	O
melanoma-19	BP
.	O

PS411	O
In	O
this	O
study	O
,	O
the	O
RET	BG
receptor	IG
tyrosine	IG
kinase-9	IG
serves	O
as	O
a	O
model	O
disease	O
gene	O
in	O
which	O
a	O
broad	O
spectrum	O
(	O
>	O
or	O
=	O
116	O
)	O
of	O
disease	O
-	O
associated	O
mutations	O
has	O
been	O
identified	O
among	O
patients	O
with	O
Hirschsprung	BP
disease-39	IP
and	O
multiple	O
endocrine	O
neoplasia-43	BP
type	O
2	O
.	O

PS417	O
In	O
conclusion	O
,	O
our	O
data	O
demonstrate	O
the	O
presence	O
of	O
somatic	O
alterations	O
of	O
the	O
MEN1	BG
tumor	IG
suppressor	IG
gene-17	IG
in	O
about	O
one	O
fifth	O
of	O
benign	O
sporadic	O
parathyroid	BP
tumors-26	IP
.	O

PS421	O
SAE1-1	BG
,	O
a	O
SUMO	BG
-	IG
1-6	IG
activating	O
enzyme	O
subunit	O
,	O
may	O
be	O
related	O
to	O
cleft	BP
lip-16	IP
and	O
palate	O
.	O

PS2787	O
It	O
is	O
concluded	O
that	O
,	O
at	O
the	O
present	O
stage	O
,	O
none	O
of	O
the	O
polymorphic	O
sites	O
determined	O
in	O
the	O
CYP	BG
genes-20	IG
can	O
yet	O
be	O
used	O
as	O
markers	O
for	O
increased	BP
lung	IP
cancer-30	IP
risk	O
.	O

PS2923	O
In	O
a	O
population	O
with	O
a	O
clear	O
-	O
cut	O
definition	O
of	O
the	O
phenotype	O
,	O
the	O
G20210A	BG
prothrombin-16	IG
mutation	O
was	O
not	O
significantly	O
associated	O
,	O
per	O
se	O
,	O
with	O
either	O
angiographically	O
documented	O
CAD	O
or	O
myocardial	BP
infarction-33	IP
,	O
whereas	O
it	O
significantly	O
influenced	O
prothrombin-39	BG
activity	O
.	O

PS2924	O
In	O
our	O
population	O
,	O
high	O
prothrombin-6	BG
activity	O
itself	O
was	O
independently	O
associated	O
with	O
CAD	O
but	O
not	O
with	O
the	O
presence	O
or	O
absence	O
of	O
previous	O
myocardial	BP
infarction-24	IP
.	O

PS2955	O
Histologically	O
,	O
five	O
low	O
-	O
grade	O
astrocytomas-7	BP
(	O
22	O
%	O
)	O
contained	O
small	O
areas	O
with	O
oligodendroglial	O
differentiation	O
,	O
but	O
this	O
did	O
not	O
correlate	O
with	O
the	O
presence	O
of	O
TP53	BG
mutations-29	IG
or	O
loss	O
of	O
heterozygosity	O
on	O
1p	O
and	O
19q	O
.	O

PS2979	O
In	O
addition	O
,	O
we	O
screened	O
patients	O
with	O
"	O
classic	O
"	O
retinitis	O
pigmentosa-12	BP
and	O
classic	O
Coats	O
disease	O
(	O
without	O
retinitis	BP
pigmentosa-20	IP
)	O
,	O
but	O
no	O
pathologic	O
sequence	O
variants	O
were	O
found	O
in	O
the	O
Crumbs	BG
homologue	IG
1	IG
gene-35	IG
.	O

PS2993	O
The	O
5alpha	BG
-	IG
reductase	IG
type	IG
II	IG
variants-7	IG
studied	O
did	O
not	O
show	O
links	O
with	O
prostate	BP
hyperplasia-15	IP
.	O

PS3065	O
Our	O
study	O
of	O
DNA	O
sequence	O
variants	O
in	O
the	O
GRM3	BG
gene-10	IG
did	O
not	O
provide	O
further	O
support	O
for	O
genetic	O
association	O
with	O
schizophrenia-20	BP
or	O
for	O
correlation	O
with	O
cognitive	BP
deficits-26	IP
.	O

PS3094	O
Gaze	O
-	O
evoked	O
nystagmus-4	BP
,	O
however	O
,	O
was	O
not	O
found	O
to	O
be	O
associated	O
with	O
SCA2-15	BG
.	O

PS3116	O
The	O
exact	O
role	O
of	O
H63D	BG
homozygosity-6	IG
in	O
iron	O
overload	O
and	O
haemochromatosis-11	BP
was	O
not	O
be	O
confirmed	O
.	O

PS3242	O
Thus	O
,	O
no	O
correlation	O
between	O
residual	O
CD95	BG
sensitivity-8	IG
and	O
clinical	O
phenotype	O
or	O
genotype	O
of	O
autoimmune	BP
lymphoproliferative-16	IP
syndrome	O
was	O
found	O
.	O

PS3328	O
Furthermore	O
,	O
we	O
did	O
not	O
identify	O
any	O
mutations	O
in	O
the	O
ADAR1	BG
gene-12	IG
of	O
three	O
patients	O
with	O
dyschromatosis	BP
universalis	IP
hereditaria	IP
or	O
three	O
patients	O
with	O
acropigmentatio	O
reticularis	O
,	O
indicating	O
that	O
the	O
two	O
diseases	O
are	O
completely	O
different	O
from	O
Dyschromatosis	BP
symmetrica	IP
hereditaria-38	IP
,	O
although	O
they	O
have	O
sometimes	O
been	O
suggested	O
to	O
be	O
phenotypical	O
variations	O
of	O
Dyschromatosis	O
symmetrica	O
hereditaria	O
.	O

PS3379	O
There	O
was	O
neither	O
a	O
significant	O
correlation	O
between	O
the	O
polymorphisms	O
in	O
the	O
TS	BG
gene-13	IG
and	O
the	O
Microsatellite	BG
instability-17	IG
phenotype	O
nor	O
between	O
the	O
mRNA	O
expression	O
and	O
Microsatellite	O
instability	O
status	O
.	O

M71	O
rs7154455-1	BG
and	O
rs3020450-3	BG
were	O
genotyped	O
in	O
sample	O
2	O
where	O
no	O
association	O
with	O
obesity-13	BP
was	O
observed	O
,	O
table	O
4	O
.	O

M74	O
no	O
esr1	BG
snp-3	IG
displayed	O
allelic	O
association	O
with	O
obesity-8	BP
or	O
lipolysis	O
.	O

M79	O
we	O
have	O
reported	O
before	O
that	O
esr1	BG
rs2234693-7	IG
and	O
rs9340799-9	BG
are	O
not	O
associated	O
with	O
obesity-14	BP
in	O
a	O
cohort	O
of	O
swedish	O
women	O
partially	O
overlapping	O
with	O
the	O
cohort	O
studied	O
in	O
this	O
project	O
[	O
16	O
]	O
.	O

M343	O
we	O
have	O
not	O
found	O
evidence	O
of	O
association	O
of	O
calpain	BG
5	IG
gene	IG
alleles-12	IG
with	O
abdominal	O
obesity-15	BP
estimated	O
by	O
waist	O
circumference	O
.	O

M399	O
anti	BG
-	IG
striated	IG
muscle	IG
antibodies-5	IG
have	O
been	O
demonstrated	O
in	O
80	O
%	O
of	O
patients	O
with	O
thymoma-15	BP
in	O
the	O
absence	O
of	O
myasthenia-20	BP
gravis	O
.	O

M432	O
it	O
has	O
been	O
concluded	O
that	O
zinc	BG
finger	IG
e	IG
-	IG
box	IG
-	IG
binding	IG
homeobox	IG
2	IG
gene-15	IG
is	O
not	O
the	O
major	O
gene	O
for	O
isolated	O
agenesis	BP
of	IP
the	IP
corpus	IP
callosum-27	IP
and	O
that	O
a	O
particular	O
attention	O
to	O
the	O
facial	O
features	O
(	O
dysplastic	BP
ears-39	IP
)	O
at	O
ultrasound	O
or	O
fetopathological	O
examination	O
may	O
help	O
the	O
diagnosis	O
of	O
mowat	O
-	O
wilson	O
syndrome	O
in	O
fetuses	O
with	O
agenesis	BP
of	IP
the	IP
corpus	IP
callosum-62	IP
.	O

M204	O
A	O
tumour	BG
necrosis	IG
factor	IG
-	IG
a-10	IG
has	O
also	O
a	O
central	O
role	O
in	O
the	O
development	O
of	O
fatty	BP
liver-21	IP
and	O
subsequently	O
non	O
-	O
alcoholic	O
steatohepatitis	O
.	O

M237	O
early	BP
graying-2	IP
of	O
hair	O
was	O
not	O
seen	O
in	O
individuals	O
with	O
5p	O
syndrome	O
and	O
with	O
two	O
copies	O
of	O
telomerase	BG
reverse	IG
transcriptase-20	IG
,	O
but	O
all	O
three	O
were	O
below	O
the	O
age	O
of	O
10	O
.	O

M257	O
Sti571	O
inhibits	O
pancreatic	O
cells	O
growth	O
,	O
but	O
these	O
effects	O
are	O
not	O
mediated	O
through	O
blockage	O
of	O
the	O
pdgf	BG
receptor	IG
tyrosine	IG
kinase-21	IG
,	O
since	O
pdgf	BG
did	O
not	O
stimulate	O
pancreatic	BP
cancer-29	IP
cell	O
growth	O
and	O
did	O
not	O
lead	O
to	O
map	BG
kinase-38	IG
or	O
pdgf	BG
receptor-41	IG
phosphorylation	O
.	O


M336	O
we	O
found	O
that	O
specific	O
calpain	BG
5	IG
gene	IG
haplotypes	IG
were	O
overrepresented	O
in	O
polycystic	BP
ovary-13	IP
syndrome	O
patients	O
.	O

M344	O
in	O
this	O
way	O
,	O
type	BP
2	IP
diabetes	IP
mellitus-8	IP
,	O
impaired	BP
fasting	IP
glucose	IP
or	O
impaired	BP
glucose	IP
tolerance-16	IP
do	O
not	O
seem	O
to	O
be	O
related	O
to	O
calpain	BG
5	IG
gene	IG
alleles-27	IG
,	O
although	O
the	O
number	O
of	O
affected	O
individuals	O
is	O
small	O
(	O
49	O
,	O
77	O
and	O
74	O
individuals	O
respectively	O
)	O
.	O

M365	O
in	O
some	O
species	O
overt	O
insulin	BG
-	IG
like	IG
growth	IG
factor	IG
2-10	IG
(	O
ILGF2	BG
)	O
is	O
thought	O
to	O
cause	O
hypoglycemia-23	BP
.	O

M381	O
several	O
studies	O
on	O
obsessive	BP
compulsive	IP
disorder-6	IP
have	O
found	O
associations	O
with	O
catecholamine	BG
-	IG
o	IG
-	IG
methyl	IG
transferase-16	IG
.	O

M425	O
this	O
variety	O
in	O
the	O
severity	O
of	O
hirschsprung	BP
disease-8	IP
in	O
mowat	O
-	O
wilson	O
syndrome	O
may	O
be	O
caused	O
by	O
both	O
variations	O
in	O
zinc	BG
finger	IG
e	IG
-	IG
box	IG
-	IG
binding	IG
homeobox	IG
2	IG
gene-30	IG
abnormalities	O
and	O
epigenetic	O
factors	O
[	O
32	O
]	O
.	O

M438	O
for	O
example	O
,	O
more	O
than	O
600	O
low	BG
density	IG
lipoprotein-9	IG
receptor	O
mutations	O
underlie	O
familial	BP
hypercholesterolemia	IP
type	IP
,	O
but	O
no	O
single	O
low	BG
density	IG
lipoprotein	IG
receptor	IG
single	IG
nucleotide	IG
polymorphism	IG
has	O
been	O
associated	O
with	O
variation	BG
of	IG
plasma	IG
lipoproteins-39	IG
in	O
the	O
general	O
population	O
.	O

M448	O
in	O
dogs	O
,	O
increased	O
plasma	O
levels	O
of	O
cardiac	BG
troponin	IG
i-10	IG
have	O
been	O
demonstrated	O
in	O
cases	O
of	O
toxaemia	BP
,	O
babesiosis	BP
,	O
myocarditis	BP
,	O
and	O
pericardial	BP
effusion-25	IP
and	O
other	O
heart	O
diseases	O
.	O

M453	O
by	O
contrast	O
,	O
overexpression	BG
of	IG
dgat1	IG
in	O
adipose	O
tissue	O
of	O
fvb	O
mice	O
,	O
a	O
strain	O
known	O
to	O
be	O
resistant	O
to	O
diet	O
-	O
induced	O
obesity	O
,	O
was	O
not	O
associated	O
with	O
obesity-30	BP
,	O
but	O
was	O
associated	O
with	O
insulin	BG
resistance-37	IP
.	O

PS13	O
This	O
study	O
describes	O
14	O
novel	O
mutations	BG
in	IG
the	IG
OPA1	IG
gene-10	IG
in	O
patients	O
with	O
autosomal	BP
dominant	IP
optic	IP
atrophy-17	IP
,	O
bringing	O
the	O
total	O
number	O
so	O
far	O
reported	O
to	O
54	O
.	O

PS16	O
GAA1	BG
mutation	IG
is	O
the	O
main	O
determinant	O
of	O
Friedreich	BP
'	IP
s	IP
ataxia	IP
phenotype	IP
and	O
GAA2-14	BG
size	O
is	O
a	O
poor	O
predictor	O
of	O
clinical	O
variation	O
.	O

PS93	O
A	O
number	O
of	O
recent	O
studies	O
suggest	O
that	O
somatic	O
mutations	O
in	O
the	O
multiple	O
endocrine	BG
neoplasia	IG
type	IG
1	IG
gene-17	IG
do	O
not	O
play	O
prominent	O
role	O
in	O
the	O
pathogenesis	O
of	O
sporadic	O
forms	O
of	O
pituitary	BP
adenoma-31	IP
.	O

PS105	O
The	O
W258X	BG
and	IG
/	IG
or	IG
R90H	IG
mutations	O
in	O
the	O
SLC22A12	O
gene	O
are	O
one	O
of	O
the	O
major	O
factors	O
responsible	O
for	O
hypouricaemia-20	BP
,	O
and	O
one	O
-	O
third	O
of	O
the	O
hypouricaemic	O
subjects	O
had	O
one	O
or	O
both	O
of	O
the	O
mutant	O
alleles	O
.	O

PS146	O
Recent	O
molecular	O
genetic	O
studies	O
have	O
linked	O
8	O
loci	O
(	O
AIPL1-10	BG
,	O
CRB1-12	BG
,	O
CRX-14	BG
,	O
GUCY2D-16	BG
,	O
RPE65-18	BG
,	O
RDH12-20	BG
,	O
RPGRIP1-22	BG
,	O
TULP1-24	BG
)	O
to	O
Leber	BP
'	IP
s	IP
congenital	IP
amaurosis-50	IP
.	O

PS185	O
Mutations	O
in	O
endoglin-3	BG
and	O
activin	BG
A	IG
receptor	IG
type	IG
II	IG
-	IG
like	IG
kinase	IG
1-13	IG
have	O
been	O
found	O
in	O
patients	O
with	O
haemorrhagic	BP
telangiectasia-26	IP
.	O

PS282	O
Comparison	O
of	O
Xylosyltransferase	O
I-4	O
activity	O
in	O
mutant	O
enzymes	O
in	O
vivo	O
and	O
in	O
vitro	O
revealed	O
that	O
heterozygous	BG
mutations	IG
are	O
not	O
involved	O
in	O
osteoarthritis-22	BP
.	O

PS358	O
Recently	O
,	O
rs613872	O
,	O
an	O
intronic	BG
variation	IG
of	IG
TCF4-9	IG
associated	O
with	O
late	BP
-	IP
onset	IP
Fuchs	IP
corneal	IP
dystrophy-17	IP
,	O
was	O
reported	O
.	O

PS464	O
Inherited	O
mutations	O
of	O
the	BG
X	IG
-	IG
linked	IG
adrenoleukodystrophy	IG
gene	IG
(	O
ABCD1-11	BG
)	O
cause	O
two	O
neuropathologically	O
distinct	O
disorders	O
:	O
cerebral	BP
adrenoleukodystrophy-20	IP
and	O
adrenomyeloneuropathy-22	BP
.	O

PS470	O
The	O
best	O
predictive	O
parameters	O
for	O
a	O
NSD1	BG
gene	IG
alteration	IG
were	O
frontal	BP
bossing-12	IP
,	O
down	O
-	O
slanted	O
palpebral	O
fissures	O
,	O
pointed	BP
chin-21	IP
and	O
overgrowth	O
.	O

PS473	O
In	O
this	O
kindred	O
with	O
Apparent	O
mineralocorticoid	O
excess	O
,	O
congenital	BP
deficiency	IP
of	IP
11	IP
beta	IP
-	IP
Hydroxysteroid	IP
dehydrogenase-19	IP
activity	O
is	O
due	O
to	O
a	O
single	O
missense	BG
mutation	IG
in	IG
exon	IG
5	IG
of	IG
the	IG
11	IG
beta	IG
-	IG
Hydroxysteroid	IG
dehydrogenase2	IG
gene-38	IG
.	O
